Cystinuria is characterized by the defect in transport of cystine (cysteine dimer) and the dibasic amino acids (ornithine, lysine and arginine) in the proximal renal tubule and the gastrointestinal tract, therefore it increases its elimination in urine and implies the formation of stones in the renal pelvis or bladder in 1-3% adults and 6-10% children. It has an incidence of 1/7000, being the autosomal recessive pattern of inheritance.
Results
In November 2017, the patient presents with nephrotic syndrome with one month of evolution with arterial hypertension, proteinuria and edema in his right knee. On the abdominal X-Ray, coral-shaped lithiasis are seen in both kidneys, being big the one on the right side, and a large vesical lithiasis. In the synovial fluid, abundant uric acid crystals are observed.
The patient is referred to the Lithiasis Unit and a decision is made to admit him in the Urology Unit in order to perform a cystolithotomy and an open pyelolithotomy. Two large calculi are received, one of them is of bladder origin with a rounded appearance, a weight of 96.98 g and a size of 60x50x34 mm, and the other of renal origin with a fragmented coral-shaped appearance, a weight of 22.80 g and a size of 36x15x13 mm. In both cases, the color is honey yellow with a porous granular structure and crystallization in hexagonal prisms. In the infrared analysis, spectrum bands are obtained at 3625-2915, 1622, 1586, 1488, 1411, 1340, 1298, 1193, 1125, 1040, 962 , 848 y 541 cm −1 , therefore the composition in both cases is 100% cystine. Given that the patient is hospitalized, a simple urine analysis is requested, with a ph of 7 and a density of 1.008, in which no crystals are observed, and the Brand's test is positive due to the appearance of an intense magenta color.
From the Laboratory, a 24-h urine study is recommended for the quantification of amino acids in urine by ion-exchange chromatography, obteining high values of cystine and dibasic amino acids (ornithine, lysine and arginine), therefore compatible with Cystinuria.
nmol/mg creatinine Normal range. Cystine 2381.55 5-150. Ornithine 591.13 10-160. Lysine 3005.79 50-900. Arginine 910.09 0-50. The patient is instructed to implement sanitary/dietetic measures, like increasing liquid intake 3 to 5 l throughout the whole day including night, in order to achieve a diuresis of 3-4 l/day and the urine density b 1.010. Also, avoid intake of animal origin proteins (1 g/kg/day) and reduce sodium intake (2 g/day). Treatment is initiated to alkalize the urine with potassium citrate and cystine chelating drugs like tiopronin.
Cystinuric patients require comprehensive follow-up because of its high lithiasic recurrence and risk of chronic renal insufficiency.
Conclusions
The particularity in this case is the presence of huge calculi in the bladder and renal pelvis with compositon of cystine and vast renal involvement derived from them.
The Laboratory is the keystone for the diagnosis as much as the follow-up, treatment and prevention in the cystinuric patients. We showed that Urine NGAL levels exhibited higher sensitivity and specificity than serum NGAL and considered to be a powerful discriminative tool between AKI and CKD. Further, urine CysC overcame serum levels against AKI-CKD prognosis, but not as sensitive as urine NGAL, an indication that CysC measurements might be affected by enigmatic non-specific factors. 
Background-aim
Background: Increased total plasma homocysteine is a risk factor for development of cardiovascular complications. In hemodialysis patients cardiovascular diseases are the most frequent cause of mortality. Aim: The aim of this study was to examine the correlation between concentration of total homocysteine in serum and echocardiographic parameters for the assessment of left ventricular hypertrophy and left ventricular dilatation and left ventricular function.
Methods
Methods: All individuals gave their informed consent for participation the study, accordnig to the Declaration of Helsinki. Laboratory investigations were performed in the Center for Medical Biochemistry at the Clinical Center of Serbia. The research was conducted on 115 patients, the average age 53.30 ± 12.17 years, (Male 71 and female 44) who were regularly treated by hemodialysis, average length of dialysis 4.51 ± 4.01 years and average Kt/Vsp index 1.17 ± 0.23. The total serum homocysteine-tHcy concentration was determined by FPIA (Fluorescence Polarization.
Immunoassay) method. Normal concentration serum tHcy is ≤15μmol / L.. Hyperhomo-cysteinemia was defined as the serum tHcy concentration N 15 mmol/L.
Results

Results:
The average value of serum total homocysteine concentration was 23.06 ± 8.58 μmol/L, diastolic thickness of interventricular septum-IVSd 11.21 ± 2.12 mm, diastolic thickness of left ventricular posterior wall-PWLVd 11.44 ± 2.09 mm, left ventricular mass index-LVMi 143.85 ± 41.21 g/m2, left ventricular end-diastolic volume index-EDVi 100.80 ± 34.62 mL, left ventricular fractional shortening-LVFS 32.52 ± 77.72% and left ventricular ejection fraction-LVEF 68.06 ± 11.11%. Statistical analysis of the results was performed by the Spearman test for rang correlation. There is a high statistically significant positive correlation between the total concentration of homocysteine in serum, thickness of erventricular septum in diastole-IVSd and thickness of left ventricular posterior wall in diastole-PWLVd, while statistically significant positive correlation was found between homocysteine concentration in serum and left ventricular mass index-LVMi. 
Methods
Observational, retrospective study of ARC treated in our emergency services of hospitals in sector I and II as well as the income from this cause in 2017 and after the implementation of the LR assessment in the urinary sediment report in 2018.
Results
During 2017, 3199 ARC were treated in our emergency services of hospitals (sector I and II), of which 286 required admission. Throughout 2018, 207 .307 urine tests were performed. The 47.0% of them presented pathological strip reason why their sediment was realized with SEDIMAX (Menarini). Of these a 2.9% were informed with LR and the implementation of hygienic dietary measures was recommended.
In 2018 ARC 3018 was treated, that is, 5.65% fewer cases.
Conclusions
In view of these results, the improvement in the quality of care of the implantation in the urinary sediment report of the result of LR detected in it, through the clinical assessment of various parameters of crystalluria from the study of nature: chemistry and size of the crystals, rate of aggregation and maclation, and overall crystalline volume, together with recommendation to implement hygienic dietary measures, suppose an added value on the part of the specialist of the laboratory, which translates into a reduction of the hospital emergencies due to ARC with consequent optimization of social and health resources and better quality of life for our patients by avoiding suffering. Laboratory "Bioticus", Prishtina, Kosovo
Background-aim
Vitamin D plays an important role in all homeostatic processes. One of the accompanying chronic kidney disease (CKD) disorders is decrease of vitamin D level. According to recent studies, patients with CKD have a high incidence of mortality resulting also from the lack of vitamin D. Considering that CKD is a frequent in our country, we aimed to identify biochemical parameters Urea, Creatinine, Calcium (Ca), Phosphorus (P) and Alkaline Phosphatase (ALP) in patients in hemodialysis, but with a special focus on vitamin D, as well as determining their correlation depending on the duration of dialysis.
Methods
This is a cross sectional study done at Clinic of Biochemistry, University Hospital of Kosovo. 48 CKD patients divided in three groups (I Group b5 years in Hemodialysis, II Group 5-10 years in Hemodialysis and III Group N10 Years in Hemodialysis) were studied. Serum levels of 25 OH-Vitamin D were measured in Mini Vidas (bio Meriux) in "Bioticus" Laboratory and Urea, Creatinine, Calcium, Phosphorus and ALP were performed and measured in biochemical analyzer "I-Lab 650" -by Instrumentation Laboratory in University Hospital Center of Pristina. All patients of the three research groups were treated in Clinic of Nephrology at UCC.
Results
In first study group the mean values of Vitamin D (10.03 ± 1.57 ng/ml), Urea (26.7 ± 6.07), Creatinine (735.8 ± 241.5 μmol/l), Ca (2.33 ± 0.11 mmol/l), P (1.5 ± 0.41 mmol/l), and ALP (99.7 ± 39.10 U/L). In second study group the mean values of Vitamin D (8.81 ± 1.29 ng/ml), Urea (31.28 ± 6.49 mmol/l), Creatinine (821.0 ± 122.2 μmol/l), Ca (2.53 ± 0.13 mmol/l), P (1.39 ± 0.47 mmol/l), and ALP (105.5 ± 47.10 U/L). In the third study group we have found mean values of Vitamin D (9.65 ± 2.30 ng/ml), Urea (29.24 ± 6.26 mmol/ l), Creatinine (823.3 ± 143.3 μmol/l), Ca (2.47 ± 0.21 mmol/l), P (1.55 ± 0.64 mmol/l), and ALP (235.8 ± 209.10 U/L).
Conclusions
Vitamin D levels decrease with disease progression and the duration of dialysis.
Vitamin D correlates negatively with urea and creatinine. Based on our results ALP concentration is increased with duration of dialysis while Vitamin D level is lower, which indicates that dystrophic changes in bone worsen with disease progression. 
Background-aim
Chronic Kidney Disease (CKD) is a global epidemic and it's prevalence in Nepal is also increasing day by day. The patients with CKD are in the highest risk group for cardiovascular disease (CVD). Various traditional CVD risk factors such as dyslipidemia and hypertension are highly prevalent in CKD but mortality of these patients cannot be fully justified by these CVD markers. So this study was designed to determine serum calcium and phosphorous product (Ca × P) to predict CVD risk in CKD patients.
Methods
We recruited 130 renal failure patients whose serum urea and/or creatinine level were N 100 mg/dl and N 2 mg/dl respectively in this cross sectional study. Serum urea was estimated by Urease-GLDH method, creatinine by Kinetic Alkaline Picrate method, calcium by Ortho Cresolpthalein Complexone (OCPC), and phosphorus by UVMolybdate method. Similarly serum Triglyceride, Total Cholesterol and HDLc levels were measured by enzymatic methods. LDLc and eGFR were calculated by Frieldwald's equation and Cockcroft and Gault formula respectively. Patients were classified into 3 different groups based on the level of Ca × P product; b40 mg2/dl2 (group 1), 40-55 mg2/dl2 (group 2) and N 55 mg2/dl2 (group 3). Further, we evaluated CVD by Left Ventricular Hypertrophy (LVH), Arrhythmia, Vulvular Heart Disease (VHD), Cardiomyopathy, Ischemic Heart Disease (IHD) and Dyslipidemia.
Results
Higher Ca × P was associated with presence of LVH (32.30% in group 1, 31.42% in group 2, and 46.66% in group 3), Arrythemia (13.84% in group 1, 28.57% in group 2, and 46.67% in group 3), VHD (5.71% in group 2, and 10.00% in group 3), Cardiomyopathy (1.53% in group 1, 8.57% in group 2 and 6.66% in group 3), IHD (6.15% in group 1, 11.42% in group 2 and 13.33% in group 3). eGFR and Ca × P were negatively correlated (r = −0.32, p b .001). LDLc level (mg/dl) was higher (p = .03) in group 3 (101.62 ± 48.45) as compared to Group 2 (90.99 ± 55.24) and Group 1 (76.36 ± 38.16).
Conclusions
This study showed that Ca × P increases with decrease in GFR and associated with CVD and CVD risks. So this study raises a potential need to evaluate the level of calcium and phosphorus in all CKD patients and the level should be monitored more thoroughly to prevent CVD. 
Background-aim
The post-infectious acute glomerulonephritis (IPNG) is an immune-based pathological process that results in a non-suppurative inflammatory lesion predominantly glomerular. Although prevalence has decreased, it is still the most frequent cause of childhood nephritic syndrome.
The group A haemolytic streptococcus (SBGA) is the germ most frequently associated with this patology. Sporadic forms usually occur after pharyngeal infection with SBGA type 12. Other infections that have been associated are malaria, hepatitis B, congenital syphilis, mumps, chicken pox, brucellosis, typhoid fever.
After infection with SBGA, there is a latency period of clinical onset of two weeks in the case of upper respiratory infection and 4 weeks after skin infections. However, in non-streptococcal forms, nephropathy is simultaneous to the infectious process.
The clinical presentation varies a lot from one patient to another. The most frequent form is the nephritic syndrome in which there may be a decrease in plasma protein, proteinuria, hypertension, oliguria and generalized edema. It is one of the common kidney diseases in childhood and is associated with a high relapse rate. The evolution is generally favorable, although severe forms may progress to chronic kidney disease.
Methods
A ten-year-old girl who has had acute tonsillitis for two years. The first episode of amygdalar infection was in March 2016, where it was treated with AZITROMYCIN 200 MG IN 5 ML/1 SUSP ORAL BOTTLE OF 30 ML, the patient presented improvement, but during that year she relapsed three times receiving the same treatment.
On 18/04 she went to the pediatrician's outpatient clinic for general malaise, accompanied by epigastric pain, nausea and vomiting, with fever associated with left lateral neck pain, pain in the right ankle and facial edema, especially at the infraorbital level.
SAT: 98%. FC: 101 lpm. Combur test: Turbid urine. Proteinuria and microscopic hematuria.
Oropharynx: Hypertrophic tonsils. Hyperemia and large amount of mucus in the posterior wall. Neck: Sensitive slipped adenopathies on the left side of the neck. Right ankle: Normal. Abdomen: Not painful to the blows of the cough, soft, depressable, no contracture or peritoneal reaction. Pain to feel the epigastrium. Abdominal sonority somewhat diminished in the gastric area. Rough skin like that of atopic dermatitis. Renal MPP: Not painful.
The routine analysis reports in the biochemistry: Uric acid 13.6 mg/dL, Creatinine 2.06 mg/dL, PCR 4.4 mg/dL, ASLO 1088 UIml. Hemogram: Hb 12.0 g/dL, hematocrit 34%, leukocytes 13.54 miles/ μL, absolute neutrophils 11.64 miles/L. Proteinogram: fraction of albumins 45.70%; proteins of the C3 complement system b4.0 mg/dl and C4 13.0 mg/dl. Urine: urinary sediment approximately 100% dysmorphic red blood cells, some hematic and granular cylinders, intense microhematuria, moderate bacteryruria. Urine biochemistry: Albumin 335.80, albumin/creatinine 1547 mg/g, Protein 443.0 mg/dl, protein/creatinine 2041 mg/g.
Results
The patient was admitted with a diagnosis of nephritic syndrome with a high suspicion of acute post-streptococcal glomerulonephritis due to a previous episode of pharyngotonsillitis with a latency period and low C3. Given the presence of edema and high BP, along with moderate-severe IRA, fluid restriction (approximately 400 ml/m2/ day), low-sodium diet and strict control of diruesis are initiated. Precise administration of furosemide during the first three days. There is a progressive decrease in blood urea and creatinine levels with a parallel increase in diuresis; Proteinuria is detected in the nephrotic range. On the third day, incipient periorbital cellulitis with progressive increase in acute phase reactants is observed, which initiates empirical parenteral antibiotic treatment, which is suspended on the 5th day with favorable clinical and analytical evolution. Seven days after admission, she had high blood pressure values, so We administer antihypertensive treatment with calcium channel blocker (nifedipine 0.5 mg/Kg/day/12 h) was added with good response. We proceed to hospital discharge for good evolution with analytical results: Total protein 6.3 g/dL; albumin 3.1 g/dL; urea 217 mg/dL; creatinine 1.72 mg/dL; PCR 15.3 mg/dL; ASLO 1088 IU/ ml; protein in urine 217 mg/dL, Protein/Creatinine (urine) 1043 mg/ g; rest of the parameters within normality. As a treatment, an antihypertensive, salt-free and low-potassium diet, continuous revisions in outpatient pediatrics are prescribed.
Conclusions
Within the blood studies are useful the complete blood count, creatinine, urea and uric acid to evaluate glomerular filtration, albumin cholesterol and triglyceride levels; The general urine test is mandatory, complement (C3 and C4), serology (antistreptolysin O and Streptozyme) to confirm the diagnosis. Hypocomplementemia is normalized in up to 90% of cases within 4 to 8 weeks. The presence of antiestrptolysin antibodies or enzymes indicative of recent infection by group A hemolytic streptococcus is normalized in a longer time, between 6 and 12 months after the condition.
Renal biopsy is rarely indicated, only in atypical situations such as prolonged C3 decrease, recurrence of hematuria, progressive increase in proteinuria and deterioration in renal function.
Most paediatric patients have an excellent prognosis. In a followup of 15 years after the acute episode, it was found that the incidence of michohematuria, proteinuria and arterial hypertension did not differ from the general population. The only data that seems to be associated with worse long-term prognosis are persistent massive proteinuria and rapidly progressive presentation.
In our clinical case as observed the clinical manifestations and laboratory tests were confirmed (GNPI). When the patient is discharged, she already has kidney function in the process of normality, discrete protein excretion and is monitored periodically by external consultation. 
Background-aim
Microalbuminuria is a marker of early kidney disease and an independent risk factor for atherosclerotic diseases. Nowadays, albuminuria detection in routine urinalysis is mainly screening test for macroalbuminuria or proteinuria. It is not an optimal screening test for microalbuminuria although the most of protein strip tests include some levels of microalbuminuria. Thus, we aimed to compare the detection of microalbuminuria by using new semiquantitative URiSCAN 2 ACR strip test and routine protein strip test with quantitative automated chemistry analyzer.
Methods
Total of 530 spot urine specimens of volunteers in CKDNET project were enrolled in the study. All specimens were analyzed quantitative levels of microalbumin and creatinine by using the SYNCHRON Lx20 PRO automated chemistry analyzer, analyzed semiquantitative levels of microabuminuria by using the URiSCAN 2 Optima urine chemistry test system, and analyzed semiquantitative levels of proteinuria with one level of microalbuminuria by using the iChem VELOCITY system in routine urinalysis.
Results
The effectiveness of URiSCAN 2 ACR strip test for microalbuminuria detection was 92.9% of sensitivity, 58.7% of specificity and 64.2% of accuracy. The false positive and the false negative rates were 41.3% and 7.1%, respectively. An agreement of URiSCAN 2 ACR strip test and the iChem VELOCITY protein strip test with automated chemistry analyzer were 60.6% and 70.4%, respectively, sensitivities of those methods were 92.9% and 89.4%, respectively, and specificities of those methods were 54.4% and 66.7%, respectively.
Conclusions
Based on high sensitivity and low negative rate of the test, URiSCAN 2 ACR strip test could be used as an alternative screening test for detection of microalbuminuria. 
Background-aim
Acute kidney injury (AKI) denotes an abrupt loss of kidney function developing within 7 days or less, resulting complications being either metabolic or systemic and death in worst cases. Damage to the kidneys in AKI is as a result of decreased blood flow (ischemia), exposure to toxic substances, inflammatory processes, or obstruction of the urinary tract. AKI is common among the critically ill children who bear an increased risk to the syndrome, incidence range from 1% -31%. Diagnosis of AKI in current practice is based on changes in Creatinine and/or urine output parameters. In circumstances where Creatinine and urine values are considered not sensitive enough additional tools are required to diagnose AKI, this is relevant in critically ill patient's population. Neutrophil Gelatinase Associated Lipocalin (NGAL) is one of the most studied AKI biomarker the driving force being on early detection of AKI and maximizing on the opportunity for early intervention translating to favorable outcomes.
The objective of this study was to evaluate ability of plasma and urine Neutrophil Gelatinase Associated Lipocalin (NGAL) to detect acute kidney injury in critically ill children at Kenyatta national hospital.
Methods
This was a prospective cross-sectional study conducted in a population of critically ill children aged between 1 and 12 years admitted at Kenyatta national hospital paediatric unit. 48 study participants were enrolled in the study, urine and blood samples were collected on the day of admission and another blood sample was collected 48 h post admission. Admission and 48 h post admission Plasma Creatinine was estimated using Dirui reagents, Admission Plasma and urine NGAL were analyzed using NGAL kit (BioPorto Diagnostics A/S, Denmark) both on Biolis 50i (Tokyo Boeki Japan) chemistry analyzer. Data was analyzed using STATA statistical package. The analysis included both descriptive and inferential analysis.
Results 40 (83.6%) participants successfully completed the study, the gender distribution was 60% (n = 24) female and 40% (n = 16) male. Majority of the participants were aged between 1 and 3 years with 75% (n = 30). The age group between 4 and 6 years accounted for 15% (n = 6), age group between 7 and 9 years 7.5% (n = 3) while there was only one participant between 10 and 12 years. 60% of all the admission was due to respiratory tract infection. 9 participants met the AKI definition giving a prevalence of AKI among critically ill children at KNH to be 28.5%, 95%CI [12.8, 41 .8] based on plasma creatinine, as well as plasma and urine NGAL.
The finding further indicate there is positive moderate relationship between plasma creatinine and Plasma NGAL (r = 0.442), and a positive insignificant relationship between Plasma creatinine and urine NGAL(r = 0.532). The findings also reveal a strong positive significant correlation between Plasma and Urine NGAL (r = 0.869). further statistical analysis show that Plasma (p = .029) and Urine NGAL (p = .000) are statistically significant predictors of acute kidney injury in critically ill children. 
Conclusions
Background-aim
Chronic kidney disease (CKD) is a condition that involves high number of population worldwide, which on its way increases the risk of cardio-vascular diseases. Among the main reasons for increased stroke evidence in patients with CKD is diabetes mellitus type 2, hypertension, and brain-vascular diseases.
Methods
We included 47 patients with chronic kidney disease (stages II to V) at "Aleksandrovska" hospital, Clinic of nephrology and Dialysis center; average age 41.9 ± 7.4. The results were compared to age and sex matched healthy controls and to patients with CKD with no atherosclerotic evidences. In the included groups were measured CBC, serum iron, ferritin, hsCRP, hepcidin. IMT was measured by using electronic calipers and evaluated by automated software programs. A cognitive function was evaluated by MMSE, CERAD, A (TMT-A), B (TMT-B).
Results
We established elevated serum hepcidin levels in CKD patients with atherosclerotic changes (204.4 ± 20.5 μg/L) compared to healthy controls (19.9 ± 2.4 μg/L), and to CKD patients without IMT changes (104.7 ± 11.1 μg/L); p b .001. Serum hsCRP concentrations were increased in all CKD patients (24.4 ± 3.1 mg/L) compared to healthy controls (0.8 ± 0.4 mg/L), p b .01. In CKD patients with increased IMT we found a positive correlation between serum hepcidin levels and atherosclerotic changes (r = 0.814, p b .005). In patients with impaired kidney function cognitive function disorders correlates to serum hepcidin levels positively (r = 0.871, p b .005). 
Conclusions
Background-aim
Studies investigating the protein composition of high density lipoprotein cholesterol (HDL) have concluded that the acute phase protein serum amyloid A (SAA) may incorporate into the HDL particle in some conditions such as chronic kidney disease. We aimed to analyzed SAA, apolipoprotein (Apo) AI, ApoAII and HDL concentrations and to test correlation between SAA and lipid status in patients on dialysis.
Methods
We examined 118 hemodialysis (HD) and 106 peritoneal dialysis (PD) patients who were treated in the Clinic of Nefrology, Clinical Center of Serbia. We measured SAA, ApoAI and ApoAII using Siemens BNII nephelometer and HDL using Beckman Coulter AU2700 Olympus analyzer, in Department of Medical Biochemistry, Clinical Center of Serbia.
Results
After the overall analysis of dialysis patients, we found significant negative correlation between SAA and ApoAI (r = −0.223, P = .001) and positive correlation between ApoAI and ApoAII (r = 0.393, P b .0001). There was stronger correlation between SAA and ApoAI in PD patients than in HD patients (r = −0.288, P = .002 vs r = −0.190, P = .045). We found no correlation between SAA and HDL in overall dialysis patients, nor any association between dialysis type and SAA concentrations. However, HDL was significantly lower, but ApoAI and ApoAII were significantly higher in the PD group.
Conclusions
Based on our results we can conclude that there is dissimilar correlation between SAA and different apolipoproteins in HDL particle, and that type of dialysis could have possible effect on HDL concentration. Future studies should reveal the mechanism of dysfunctional formation of HDL in patients on dialysis, and also clarify whether the dialysis modality affects the shift towards proinflammatory lipoprotein status. 
Methods
The aim of this work is to show the state-of-the-art of the LD of CKD in our country and summarize the recommendations mentioned on KDIGO. Introduction: Anemia in patients with chronic renal insufficiency (CRI) is multifactorial, but is predominately conditioned by relative deficit of erythropoietin. Hepatitis (B and C) is also a common complication of patients on dialysis.
Results
Serum
Goal of the article: Goal of the article was markers analysis of anemic syndrome in patients on chronic hemodialysis and comparison with the same markers in healthy population. Simultaneously, comparison of these parameters has been done in relation to the existence of hepatitis. 
Background-aim
Anemia is a regular companion of chronic renal insufficiency (CRI) and often requires therapy with erythropoiesis stimulators.
Goal of the article: Goal of the article was to examine effects of subcutaneous administration of recombinant human erythropoietin (rHuEPO) on the anemia correction in patients on dialysis.
Methods
Study followed 30 patients who are being treated with hemodialysis in Center for nephrology and hemodialysis of Medical center Vranje. To each patient certain blood count parameters, concentrations of iron and ferritin were measured before and 4 months after the administration of rHuEPO. Control group consisted of voluntary blood donors.
Results
The administration of rHuEPO led to an increase in hemoglobin concentration (p = .05), hematocrit, reticulocyte (p b .01) and a significant decrease in iron and ferritin concentrations (p b .01). In relation to the control group the blood count parameters are significantly reduced and the level of ferritin is still high.
Conclusions
In examined patients, who are on chronic programme of hemodialysis, four-month administration of rHuEPO led to an increase in levels of hemoglobin, hematocrit and a significant increase of reticulocytes, namely, to successful correction of anemia. There has been a decrease in concentration of iron and ferritin even though iron was administered which is explained by the role of iron in the hemoglobin synthesis. There is an increase in platelets values but within the limits of reference values. 
Background-aim
Diabetes mellitus represents a public health problem affecting around 8.5% of the population worldwide. Morbidity and mortality complicate a late diagnoses, which leads to chronic kidney disease (CKD) increasing the cost in the healthcare system. The present study was conducted in the municipality of Copalillo, Guerrero Mexico where diabetic patients attended the Healthcare Center during the year 2018, aiming to know the prevalence of occult renal disease (ORD).
Methods
The total population included 86 adult diabetic patients and 114 non-diabetic, of which 71.3% (142) were female and 29% (58) male. Anthropometric measures, a socio-economic survey and serum and urinary biochemical measurements were performed. The CockroftGault equation was used to estimate the glomerular filtration rate (eGFR).
Results
Diabetic patients had 52.8% of relatives with diabetes in maternal line mainly.
Anthropometric parameters, systolic blood pressure (SBP), diastolic blood pressure (DBP), and biochemical parameters, glucose, creatinine, urea, microalbuminuria, and eGFR showed increase in the mean in a manner directly proportional to the increase in (BMI) body mass index, finding a statistically significant difference in the mean values for creatinine, urea, eGFR, SBP, DBP, size and weight mainly in men with diabetes.
Conclusions
The study allowed us to identify 1.5% of diabetic patients with established kidney disease, while another 4% had ORD that meant a proportion of 1: 2.6. We did not find any case of ORD in the nondiabetic group. 
Background-aim
Changes in the color of urine may be a concern for the patient and health care professionals. The scarce bibliography that gathers the underlying causes of these changes is outdated. The updated information refers only to description of clinical cases.
The knowledge of the causes of urine color changes in the laboratory becomes essential for the clarification of patients and health professionals, as well as for the reduction of unjustified laboratory tests, in order to clarify these situations. The laboratory will thus demonstrate its fundamental role in rationalizing health care costs.
Methods
In order to gather the most recent information related to the subject, articles were searched in Pubmed, with the keywords "urine color", "green urine", "black urine", "white urine", "Brown urine", "urine discoloration", etc.
After analysis of the literature, the urine color changes were grouped into 6 groups: red, orange, white, green/blue, brown and black.
For each group, the causes responsible for color change were included in 3 subgroups: drugs (D), pathology (PA) and others (O).
Results
The 164 causes of urine color change found in Pubmed search were distributed as follows (examples):
Red: D (chloroquine, warfarin and ibuprofen); AP (hemolytic anemia, thrombotic thrombocytopenic purpura (PTT) and idiopathic (ITP), porphyrias); O (beet).
Orange: the above and D (isoniazid, riboflavin Black: D (laxatives, metronidazole, iron, cresol, chloroquine); AP (melanoma).
Conclusions
The knowledge of the different causes of urine color changes, together with the integration of this information with the results of other laboratory tests, can mark the excellence of a laboratory, which will be able to guide the choice of additional complementary tests necessary for the full understanding of the cause of the change in urine color. This knowledge and this attitude will reinforce the laboratory's role in rationalizing health care costs. 
Background-aim
Microalbuminuria (mAlbu) is a sensitive marker of kidney damage and an independent factor of cardiovascular risk. The aim of our study was to study the performance of Microalbumin 2-1 Combo® test strips (BTNXinc) in the detection and quantification of microalbuminuria compared to a quantitative method.
Methods
Our study involved 41 urine samples obtained for determination of mAlbu. The test strips, using the tetrabromosulfonaphthalene reaction, classify mAlbu into four categories (10, 30, 80 and 150 mg/ L). They also allow the estimation of urinary creatinine (CRu) in five categories (0.9, 4.4, 8.8, 17.7 and 26 .5 mmol/L). Thus with this strip, the albumin/creatinine ratio (ACR) will be classified into three categories (b3.4, 3.4-33.9 and N 33.9 mg/mmol). Assays for mAlbu (immunoturbidimetric method) and CRu (Kinetic Jaffee Method) were performed on ADVIA® 1800 from Siemens.
Results
The reliability of the strips in the mAlbu estimation was comparable as well using the absolute value of mAlbu (threshold b20 mg/L) as the value of ACR thresholds b3.4 mg/mmol (F) and b 2.5 mg/mmol (H). In fact we observed a sensitivity of 87.5% vs 90%, a specificity of 30.3% vs 22.6%, a negative predictive value of 90.9% vs 87.5% and a positive predictive value of 23.3% vs 27%. Referring to the categories reported by the test strips, 75.6% of the mAlbu values and 65.85% of the ACR values obtained by quantitative method were misclassified.
Conclusions
Using Microalbumin 2-1 Combo® Test Strips for mAlbu detection, 9.1-12.5% of subjects may be falsely thought to be safe which limits their use as a screening tool for mAlbu. 
Background-aim
The quantification of urinary proteins is very important to evaluate the different kidney diseases. In our hospital we follow the protocol developed by Dr. Bergon et al. (2002) , in which the total protein, 〈-1 microalbumin, albumin and immunoglobuline G values are evaluated, among others.
Nowadays, the albumin in urine samples can be analyzed using different methods such immunoturbidimetry or immunonephelometry. However, the absence of a reference material represents an important disadvantage of them. For this reason, it is very important to have the most specific and sensitive determination available in order to obtain the highest accuracy in the proteinuria classification.
With the aim of detecting significant differences between the two methods, we carried out a comparative study using samples analyzed by both ways.
Methods
Albumin was measured in 563 samples of 24-h urine collections. All samples were processed the day of reception, and after centrifugation at 1500g for 5 min. Samples urines with gross hematuria or albumin analyzed only by one method, were excluded. The albumin analysis was carried out by immuturbidimetry (Cobas C 701, Roche) and immunonephelometry (BN ProSpect System, Siemens). For the statistical study, the Wilcoson test was applied using the R-Commander software.
Results
The protocol used in our laboratory classified 563 samples analyzed by immunonephelometry as selective glomerular pattern (23%), non-selective glomerular pattern (3%), glomerular pattern (10%), tubular pattern (15%) and mixed pattern (21%). In addition, 8% of them correspond to samples with proteinuria and no specific protein affected, and 20% of samples did not present proteinuria.
Significant differences were detected when the albumin urine was analyzed either by immunephelometry or immunoturbidimetry (p b 2.2 × 10 −16
), which would involve that 6% of the total samples would change their classification depending on the method used.
Conclusions
Despite immunonephelometry and immunoturbidimetry are validated for the albumin urine analysis, there are significant differences between both methods. Thus, if we want to apply a protocol to classify with high accuracy the proteinuria, we should consider how to analyze both the albumin and the rest of the specific proteins. 
Background-aim
Methotrexate (MTX), in low dose is one of the most frequently used antirheumatic drugs in patients with rheumatoid arthritis (RA), because of its benefit and risk profile. Glomerular filtration is the dominant pathway of MTX elimination. Our study wants to determine the effects of impaired renal function on the pharmacokinetics of MTX in RA patients and possible hepatotoxicity.
Methods
38 RA patients were included in this study. MTX was administered intramuscularly (7.5-15 mg). Subjects were divided into three groups, according to their creatinine clearance (CLCR); group 1: CLCR lower than 45 ml/min; group 2: CLCR between 45 and 80 ml/min and group 3: CLCR higher than 80 ml/min. Blood samples were collected from each subject, 2, 12 and 24 h after drug administration. We determined concentrations of MTX and transaminase liver enzymes.
Results
MTX concentrations were 1.2 to 1.5-times higher in group 1 than in groups 2 and 3. Total MTX t 1/2 eliminations were 23 h in group 1, 12.8 h in group 2 and 10.5 h in group 3. Linear regression revealed good correlations between clearance values of MTX and creatinine clearance. Elevated ALT/AST levels occurred in 30% patients, 12 h after MTX therapy in group 1, 10% and 7% of patients in group 2 and 3.
Highest level of ALT is 96 IU/L, AST 62 IU/L.
Conclusions
Eliminations half life was significantly increased and total clearance was significantly reduced with the degree of renal impairment. Longer elimination half life induced increased chance of liver dysfunction. to estimate glomerular filtration (GFe). CKD-EPI is the most accurate formula, reduces the prevalence of Chronic Kidney Disease (CKD) and improve the risk prediction.
Our goal was to compare the results obtained by using the CKD-EPI and MDRD-4 (Modification of Diet in Renal Disease) used in our laboratory.
Methods
Data was collected from 2706 patients, 49% women and 51% men. The serum creatinin determination (mg/dL) was obtained by using the Jaffé modified method in an ADVIA 1800 Chemistry System® (Siemens Healthineers).
GFe was calculated (mL/min/1.73m
2 ) and we included in the results a clinical remark on the CKD stage. For MDRD-4 there are 4 stages according to GFe (1 or 2, 3, 4, and 5). For CKD-EPI there are 6 stages (1, 2, 3a, 3b, 4 and 5).
The total percentage was calculated, according to the patients in each stage and it was studied if there were any significant differences (p N .05).
Results
According to the MDRD-4, for stage and gender, the percentage of classified patients was: stage 1-2, female (66%), male (66%), total (66%); stage 3, female (26%), male (23%), total (24%); stage 4, female (5%), male (5%), total (5%); stage 5, female (3%), male (6%), total (5%).
Using the CKD-EPI equation the percentage was: stages 1-2, female (67%), male (66%), total (7%); stages 3a-3b, female (24%), male (22%), total (23%); stage 4, female (6%), male (6%), total (6%); stage 5, female (4%), male (6%), total (5%).
The correlation coefficients between both equations were: stages 1-2, female (0.00), male (0.00), total (0.00); stage 3, female (0.82), male (0.09), total (0.18); stage 4, female (0.22), male (0.11), total (0.05); stage 5, female (0.41), male (0.09), total (0.07).
Conclusions
For GFe values there are significant differences between the equations studied for stages 1 and 2 in male, female and total groups. There are no differences for the other stages.
CKD-EPI and MDRD-4 classify the patients in the same stages 3, 4 and 5. According to the bibliography, they improve prediction of complication risk in CKD.
For 1 and 2 stages, it would be necessary to continue further study of the GFe equations in this group of patients. 
Background-aim
In the workup for Urinary Tract Infections (UTI), automated urinalysis is a simple test procedure facilitated by accurate biochemistry and the elucidation of formed elements either by imaging or flowcytometric measurement. However, additional detection parameters can add value and facilitate a more a targeted intervention from the beginning. In addition to performing a bacteria count, the Sysmex Uf-5000 (Kobe, Japan) includes a feature that is able to predict the Gram type of an organism.
Methods
Ten American Type Culture Collection strains of Gram positive and negative bacteria commonly found in UTI were cultivated to provide a pure stock for analysis. These included both rod and cocci organisms. Serial dilutions were made using element negative urine from anonymized sources and run as patient samples. Furthermore, a mixing study was conducted consisting both Gram positive and negative bacteria.
Results
The Gram positive cohort comprised of three cocci and one rod shaped organism; the measured ranges were from 15 cells/uL to 26,168 cells/uL. The Gram negative cohort comprised of five rod shaped and one cocci organism; the measured ranges were from 25 cells/uL to 62,582 cells/uL. The instrument failed to predict the Gram type at 69 cells/uL and 101 cells/uL for Gram positive and Gram negative bacteria, respectively. In the mixing study, the instrument reported Gram negative in a mixture of bacteria above 3501 cells/uL while it could only call Gram positive at a level of 6416 cells/uL and above. It pronounced mixed types at 3981 cells/uL. In addition, two Gram negative organisms were repeatedly misclassified as Gram positive, irrespective of the organism count.
Conclusions
The adjunctive information of organism Gram type can provide information leading to a faster and more targeted treatment of patients with UTI. However, if this feature were to be used on samples analyzed by the Sysmex Uf-5000, it must be accompanied by a comment stating that possible misclassification can occur for at least two species of bacteria. Additionally, in the event of a mixed infection, the organism with the higher count will in all likelihood mask the Gram prediction of a species with a lower count. 
Background-aim
The most frequently observed crystals in urinary sediment are calcium oxalate, uric acid and phosphate. Ammonium magnesium phosphate or struvite and ammonium urate crystals can also be found. These are less frequent and secondary to urinary tract infection, related to ureolytic germs.
These germs release large amounts of urease, which hydrolyzes urea excreted in urine into ammonia and CO 2 . Ammonia is hydrolyzed to ammonium hydroxide and CO 2 is converted to bicarbonate, resulting in a strong alkalinisation of urine that causes the mobilization of phosphates. These bind to ammonium which picks up available magnesium and calcium, forming magnesium ammonium phosphate and calcium phosphate.
Therefore, the presence of crystals also depends on certain pH ranges and urinary volume. In the case of struvite, a pH higher than 7.2 and the binomial alkalinisation and ammonia are necessary.
The objective was check whether the flora observed in urinary sediments with struvite crystals corresponds to the presence of ureolytic germs.
Methods
Retrospective observational study in which struvite crystalluria observed in automated urinary sediments is analyzed with the SEDIMAX instrument (Menarini) and its relation with the results of the urine culture.
Results
During 2018, a total of 207,307 urine samples were routinely analyzed. The 47% of them presented pathological strip, so their sediment was performed, being only 574 (0.6%) in which the combination of struvite crystals along with flora was observed, but a urine culture was performed to only 237 of them (41,3%).
In 81% of these, ureolytic germs were found, with Proteus mirabilis being responsible for urinary tract infection in 136 patients. Other minority ureolytic microorganisms were found.
Conclusions
The low percentage of urine with the combination of flora and struvite crystals is due to the large number of samples processed.
In spite of this, it can be affirmed that in most of those samples, as found in the bibliography, ureolytic germs are responsible for the formation of these crystals.
In our environment, the most prevalent is Proteus mirabilis, being present in over half of the patients' urine cultures.
From the Laboratory, the contribution to the requesting physician of the comment "to assess ureolitic germs infection" in the report of the urinary sediment represents an advance in the orientation of the empirical treatment before knowing the result of the urine culture. 
Background-aim
Hypouricemia may lead to nephrolithiasis or acute renal failure. However, it didn't get enough attention by clinicians as the low incidence rate. To date, no data about the prevalence of hypouricemia has been reported in China. This study was to examine the prevalence of hypouricemia based on a representative multicenter population in China.
Methods
Data came from the Chinese Physiological Constant and Health Condition. Participants included 22,769 participants (10,573 men and 12,196 women) ages ranging from 18 to 98 years old, who were recruited from six representative provinces of China during 2007-2011. Questionnaires and physical examinations were performed and fasting blood was collected for biochemical tests. Hypouricemia was defined as serum UA less or equal than 119 μmol/L (2.0 mg/dl).
Results
The prevalence of hypouricemia was 0.7% (160/22769). Results indicated that females had a higher prevalence rate of hypouricemia than males (1.1% vs.0.3%, p b .05). Participants from the Ningxia Hui autonomous region had a higher rate of hypouricemia than subjects from other provinces (p b .01). Female subjects had a significantly lower UA concentration than males (258.2 ± 68.0 vs. 346.3 ± 84.4 μmol/L, p b .01). Participants from Ningxia Hui autonomous region and Korean ethnic group had a higher odds ratio of hypouricemia than other provinces and ethnic groups, respectively.
Conclusions
Hypouricemia prevalence was higher in women than in men. Gender, ethnic group and geographic region were associated with hypouricemia prevalence. Our findings provide fundamental data for hypouricemia prevalence in China and would be the foundation for future research. 
Background-aim
In peritoneal dialysis, the determination of creatinine in dialysates is subject to interference because of the presence of high glucose concentration. More efficient and more specific techniques such as high performance liquid chromatography (HPLC) are therefore suitable in these clinical situations.
Methods
Measurements of creatinine concentration with increasing concentrations of glucose, simulating those observed in peritoneal dialysis bags was performed. The assays were performed by a validated internal method using high performance liquid chromatography coupled to a diode array detector (HPLC-DAD) at the Biochemistry Department, University Hospital of Oran «1er Novembre 1954». The studied concentrations are respectively 10, 20, 30, 40 and 50 g/L for glucose and 2.5, 5, 10 and 15 mg/L for creatinine. A comparison of the creatinine assay values by HPLC-DAD and the Jaffe method was then performed on patient dialysate samples. For the chromatographic analysis, a C18 column, a mobile phase (phosphate buffer mixture pH 7, methanol (99/1, v/v)), UV detection at 235 nm and a mobile phase flow rate of 1 ml/min were used. The concentrations are calculated with reference to a calibration curve. Statistical analysis included the Bland & Altman graphical method, linear regression and calculation of interference percentages.
Results
The Bland & Altman graphical representations show an agreement between the concentrations values of creatinine standard solutions and the measured values of creatinine by HPLC. For the tested glucose concentrations the regression coefficients indicate a high correlation (r2 ε0.998). The calculated interference percentages do not exceed the acceptable limits of ±10%. In dialysate samples, for high glucose concentrations, elevated creatinine values were observed with the Jaffe method however HPLC creatinine values were always found to be lower.
Conclusions
The HPLC-DAD assay method remains a very sensitive, specific and accurate method. It also offers the opportunity to analyze creatinine in dialysate solutions even in the presence of high glucose concentration without interferences. 
Background-aim
Nephronophthisis is an autosomal recessive hereditary disease which progresses to terminal renal failure, being the most frequent genetic cause of transplantation before the third decade of life. The disease is classified as a child, juvenile or adolescent based on its debut. Mutations are known in nine NPHP genes, being NPHP1 the most prominent (20% of cases) located on chromosome 2 and encoding the protein nephrocystin, involved in the maintenance of the renal tubules. The symptoms are polyuria, diluted urine and anemia. The diagnosis is genetic and supportive treatment until a renal transplant is required.
Methods
Case report: 10-year-old girl who goes to pediatrics for excessive thirst and frequent vomiting. Physical examination reveals pallor, dehydration and hypotension.
Results
Blood analytics: hemoglobin = 9.7 g/dL (12-16), hematocrit = 28% (35-45), urea = 25 mg/dL (17-43), creatinine = 3.5 mg/dL (0.5-0.9), calcium = 11.1 mg/dL (8.8-10.6) and metabolic acidosis. Serotherapy is started with bicarbonate and extends urine tests: albumin/creatinine = 65 mg/g (0−30), ® 2 -microglobulin = 20.8 mg/L (0-0.4) and glomerular filtration rate = 23 mL/min/1.73 m2 (N60). The genetic study detects mutation in NPHP1 by homozygous 2q13 deletion. Treatment is prescribed for control of the electrolyte balance and anemia, along with peritoneal dialysis. At age 16 she develops chronic renal failure stage IV emerging complications such as hyperkalemia, hyperuricemia and severe hyperparathyroidism. After parathyroidectomy and pretransplant waiting list a renal graft from a cadaver donor is practiced. The biopsy confirms subacute corrected rejection with immunosuppression and corticoids. Currently the patient is 19 years old, monitored by nephrology and hematology, good general condition and normal life.
Conclusions
The recent diagnosis and pathogenesis of nephronophthisis is crucial, due to its rapid progression to terminal renal failure and other secondary alterations. The treatment of anemia and hyperparathyroidism is complicated, as well as evaluating the compatibility of transplantation when required. The incidence of the disease is estimated at 1/50,000, in an isolated form or combined with the Senior-Løken (retinal degeneration and blindness) or Joubert (neuropathy by cerebellar hypoplasia) syndromes. 
Background-aim
Metabolic acidosis (MA) in hemodialysis (HD) patients can lead to various complications and guidelines recommend raising plasma bicarbonate (BIC) levels to ε22mEq/L. However, alkaline pH could have undesirable effects on calcium-phosphate metabolism and vascular calcifications (VC). Pre-dialysis (preD), immediately postdialysis (postD) and one hour post-dialysis (1hpostD) acid-base status was investigated in association with changes in serum calcium and phosphate levels.
Methods 25 anuric patients, M/F = 20/5, aged 62 (42-87)years, on standard HD treatment since 37 (8-251)months, dialyzed with a dialysate (d) BIC concentration of 32 mM and dCa concentrations of 1.5 or 1.25 mM, with Kt/V N 1.2, were studied. PreD, postD and 1hpostD blood was sampled for pH, BIC, ionized Ca (iCa), phosphate (sP), total Ca and albumin. Corrected for albumin Ca (sCa) and sCa x sP product (CaxP) values were calculated.
Results
Before session all patients presented with MA. At the end of the session both pH and BIC increased (pH: 7.33 ± 0.06 to 7.43 ± 0.05-p b .001, BIC: 21 ± 2.8 to 26.4 ± 1.6 mM-p b .001). 1hpostD pH and BIC were higher than preD values (7.43 ± 0.05 and 25.7 ± 2.2 mM-p b .001 respectively), remaining similar to postD values. Compared with preD sCa (9.1 ± 0.7 mg/dl), both postD sCa and 1hpostD sCa were higher (10.2 ± 0.8 mg/dl and 10.04 ± 0.9 mg/dl-p b .001 respectively), with no difference between postD sCa and 1hpostD sCa. PreD iCa remained unchangeable at the end and 1 h after HD session (0.86 ± 0.1, 0.86 ± 0.2 and 0.90 ± 0.2 mM respectively). At the end of HD session sP decreased in all patients (5.8 ± 1.7 to 3 ± 0.7 mg/ dl-p b .001). There was a sP rebound 1 h after session (3 ± 0.7 to 3.7 ± 0.9 mg/dl-p b .05) with 1hpostD sP remaining however lower than preD sP (p b .001). CaxP values followed sP changes (52.2 ± 13.2 to 30.8 ± 7.7 to 36.8 ± 10.2 mg2/dl2). Significant correlations of pH increase were found with preD CaxP (R = 0.642-p b .001) and 1hpostD CaxP (R = 0.470-p = .03).
Conclusions
Under the use of a relatively low dBIC, metabolic alkalosis was observed at the end and 1 h after HD session with increased postD pH, BIC and sCa values remaining unchangeable and constantly high 1 h after HD session. These alterations combined with the sP rebound may increase the risk of calcium phosphate apatite precipitation and VC. 
Background-aim
Chronic kidney disease (CKD) is a major public health problem in Thailand. Since CKD, especially at the end stage, need the continuous treatment, therefore, its country economic burden. The ABO blood group is the major clinical significant blood group. The type of ABO blood group depends on the type of glycolipid antigen on red blood cells that encoded by genes. Previous studies showed that ABO blood group has an association with some diseases such as cancer, stroke and diabetes mellitus. However, a few studies have reported on ABO blood group and chronic kidney disease with inconsistent of the result. The purpose of this study was to explore the distribution of ABO blood group in chronic kidney disease patients compared with the normal population.
Methods
Microplate technique was used to detect ABO blood group in chronic kidney disease patients and normal population in Don Chang district, Muang Khon Kaen, Khon Kaen.
Results
A total of 860 participants consisted of 287 males (33.37%) and 573 females (66.63%) between the age of 18-86 years were studied. The distribution of ABO blood groups in 285 chronic kidney disease patients (33.14%) versus 575 normal (66.86%) was B in 120 (42.11) versus 235 (40.87%), O in 93 (32.63) versus 194 (33.74%), A in 52 (18.25) versus 103 (17.91%), and AB in 20 (7.02) versus 43 (7.48%). The statistical analysis showed a non-significant difference in frequency of ABO blood groups between CKD and normal (p = .976).
Conclusions
The result of this study indicated that no association between ABO and chronic kidney disease. However, as a small number of the population in this study, more study is needed to confirm the finding. 
Background-aim
Myoglobinuria induces acute renal insufficiency (ARF) and might result in death by electric injury. Myoglobin causes reduced blood circulation through the kidneys where the reduced glomerular filtration already exists as a result of hypovolemia, as well as causing the entire obstruction of the renal channels. The objective of our study is to determine which clinical-pathological variables point to the occurrence of ARF.
Methods
The concentration of myoglobin in serum was determined by the CLIA method (sendwich chemiluminescence assay) on ADVIA Centaur in patients with electrocution, 12 h upon hospital admission. In urine myoglobin was detected qualitatively. The examination included 28 patients that suffered electric shock who were hospitalized between the year of 2015 and 2018.
Results
Of all patients 18% had myoglobinuria, while only 1 patient developed ARF. Logistic regression analysis proved that the following clinicallaboratory parameters correlate with myoglobinuria: creatine concentration in serum, activity of creatine-kinase enzyme as well as the prehospital cardiac arrest, existence of deep burns. Utilizing the prediction model: positive when having ε2 risk factor, can be significantly increased sensitivity of the method for defining patients at risk.
Conclusions
The patients with myoglobinuria had little risk of developing ARF. This rule of prediction can be used as screening whereby patients would be put in two groups: those with low risk and those with the high risk of develop ARF, whose treatment requires a more aggressive therapy. 
Background-aim
Analyzing the celularity in a body fluid (BF) provides important information in various medical conditions and in certain cases is the key to the diagnostic.
Automated body fluid cell count systems have been introduced in the clinical laboratory and their use may reduce interoperator variability, improve precision and response time. The Sysmex XN is a hematology analyzer (Sysmex Co. Kobe, Japan) who has incorporated a body fluid module (XN-BF) that can be used as an alternative for the manual cell counting. It also offers the possibility of the differential counting.
We compare the traditional manual cell and differential counting of BF with the results given by Sysmex XN BF.
Methods
We choose one hundred BF samples (peritoneal, pleural, synovial and cerebrospinal fluids) that entered the Emergency Laboratory consecutively for a three months period. With all the samples we proceed with the manual counting using Neubauer chamber and the differential counting in polymorphonuclear (PMN) and mononuclear (MN) cells using Turk solution. Each sample was also processed with XN-BF.
We apply the Passing and Bablok regression and Pearson's correlation.
Results
The comparison between XN-BF and manual cell counts for white cell shows a Passing and Bablok regression between 0,19 (95% CI, −1,37 a 2,30) and 1,31 (95% CI, 1,20 a 1,46) ; when compare PMN and MN differential counting we found a Passing and Bablok regression between -1,61 (95% CI, − 8,01 a 1,97) and 1,02 (95% CI, 0,94 a 1,11) for the PMN, and − 0,73 (95% CI, −2,82 a 3,28) and 1,02 (95% CI, 0,94 a 1,11) for the MN.
The Pearson's correlation for the white cells count showed a coefficient of 0.93% p b .005 and for the red blood cells was 0.95% p b .005.
Conclusions
In general the use of automated blood analyzers may be helpful in Clinical Laboratory. Their use may be an option depending of the type of body fluid. However manual light microscopy remains the "gold standard" for counting and differentiating total cells. 
Background-aim
Nephrolithiasis is a multifactorial metabolic disorder that leads to the formation of stones in the urinary system. Personal factors such as age, sex and metabolic disorders, as well as environmental factors such as the geographical area affect this disease. Nephrolithiasis in Europe has a high recurrence, a prevalence of 10% and it is more common in men than in women. Regarding the composition, kidney stones can be pure (formed by a single component) or mixed (with several components). Among them, the predominant component is calcium oxalate, followed by uric acid.
The aim of this study is to elucidate the chemical composition of kidney stones analyzed in our laboratory, their distribution according sex and age and patients with recurrences.
Methods
Observational, retrospective and descriptive studies of urinary stones were accomplished from 2010 to 2017. The variables studied were sex, age and chemical composition. To identify their composition, the samples were analyzed by stereoscopic microscope and infrared spectroscopy. The results were exported with the program Modulab Gold of Izasa, and the statistical analyses were performed with the computer program Microsoft Excel.
Results 1829 urinary stones have been analyzed; from 1600 patients (169 patients had recurrences).
Prevalence in men and women was 66% and 34% respectively, furthermore, the disease has a different predominance during age periods: until 19 years 2% of total cases, between 20 and 39 years 18%, between 40 and 59 years 45%, between 60 and 79 years 31% and in older than 80 years 4%.
On one hand, the 77% of the kidney stones were pure and among them 72% were formed by calcium oxalate mono-or di-hydrate, 21% by uric acid and 7% by other components. On the other hand, the 23% were mixed, among them 71% had predominance of calcium oxalate, 13% had phosphate predominance and 10% were of infective type, mainly struvite.
Conclusions
The results obtained confirm that kidney stones are predominant in male sex and between the 40-59 years.
Calcium oxalate is the main component of pure kidney stones followed by uric acid, this agrees with other studies previously performed. Whereas, in mixed composed stones the most abundant were those with calcium oxalate, followed by phosphate predominance. 
Background-aim
Serum creatinine is used to evaluate the renal function. The glomerular filtration rate (GFR) estimated with creatinine is a helpful tool for the physicians to classify the patients into different stages of the Chronic Kidney Disease (CKD). There are different methods for the quantification of serum creatinine. In our laboratory the method used is kinetic Jaffé's. Analytical problems are associated with the use of Jaffé's reaction, especially in paediatric population where there are lower levels of creatinine and higher variability in the chromogens concentration. In that particular population different authors and scientific societies recommend the use of enzymatic methods. We aim to compare both methods on Abbot Architect ci8200 and study whether it was necessary to start using the enzymatic assay in our paediatric population.
Methods
Creatinine was analyzed by kinetic Jaffé's and by enzymatic method in 207 blood samples from our paediatric patients (from 2 months to 18 years old). Data were analyzed by using regression analysis to compare both methods and paired t-test to assess the significance of difference. The estimation of the GFR was calculated using Schwartz IDMS and then classified into different stages of CKD.
Results
Samples were analyzed separately b0,9 mg/dL (group I) and N 0,9 mg/dL (group II). There are statistically significant differences between both methods. In group I, creatinines by Jaffé's assay have higher values (0,60 ± 0,13 mg/dL) than enzymatic's (0,57 ± 0,20 mg/dL). In group II, enzymatic assay gives higher values (1,86 ± 0,75 mg/dL) than Jaffé's (1,77 ± 0,74 mg/dL). Correlation coefficient r is 0,92 and 0,97 in groups I and II respectively.
When samples are classified in each group of CKD stages according to its GFR, those estimated with Jaffé's creatinine had 77 samples classified in G1, 59 in G2, 20 in G3a, 23 in G3b, 11 in G4 and 5 in G5. Those estimated with enzymatic's creatinine had 90 in G1, 43 in G2, 16 in G3a, 30 in G3b, 10 in G4 and 6 in G5.
Conclusions
After the results obtained we can conclude that even though there are statistically significant differences between the two methods, the difference is of little consequence clinically speaking and does not justify the economic gap between them. And therefore, we decided to remain using Jaffé's assay. 
Background-aim
Increased concentration of uric acid (UA) is frequently encountered in end-stage renal disease (ESRD). Furthermore, hyperuricemia is related with an increased cardiovascular risk. Our was to assess the association between UA and other laboratory markers of renal impairment, as well as the presence of certain cardiovascular complications in patients with ESRD.
Methods
A group of 110 patients on a chronic hemodialysis program was evaluated from 2011 to 2017. Clinical assessment included age, gender and body mass index (BMI), mean arterial blood pressure and presence of secondary hypertension, chronic ischemic myocardiopathy or development of acute coronary syndromes. Laboratory tests involved UA, glucose, urea, creatinine, albumin, total, HDL and LDL cholesterol, triglycerides, calcium, inorganic phosphate, Creactive protein, natriuretic peptide type B (BNP), amino-terminal pro-natriuretic peptide type B (NT-proBNP) and intact parathyroid hormone (iPTH). Patients were grouped depending on whether UA was below or above 350 μmol/L. Clinical and laboratory data were compared between groups using Student t or Chi-square test, while their association with UA in the whole cohort was assessed with Spearman's correlation analysis.
Results
Uricemia above 350 μmol/L was more frequently encountered in males (P = .0126). Also, higher concentration of urea (P = .004), creatinine (P = .028), triglycerides (P = .049), inorganic phosphate (P = .001) and CRP (P = .041), as well as lower level of HDL cholesterol (P = .005), were measured in group with UA higher that 350 μmol/L. Level of UA correlated with male gender (r = 0.233; P = .014), age (r = −0.331; P = .001) as well as concentration of urea (r = 0.355; P = .001), creatinine (r = 0.288; P = .004), HDL-cholesterol (r = −0.357; P b .001); triglyceride (r = 0.288; P = .002); inorganic phosphate (r = 0.441; P b .001), BNP (r = −0.319; P = .029) and CRP (r = 0.212; P = .031). Nevertheless, no significant correlation was found between UA level and presence of abovementioned cardiovascular complications.
Conclusions
In the study group, concentration of UA correlated with laboratory markers of renal impairment, while association with certain cardiovascular complications of ESRD was not evidenced. 
Background-aim
Reporting of acanthocyturia is useful in early diagnosis of glomerular diseases. UriSed 3 Pro is a new automated microscopy urine analyzer which evaluates erythrocyte morphology by using built in light microscope and phase contrast microscope. It shows a flag message for the presence of acanthocyte N5% in urine sample. Thus, we aimed to verify the flag for detection of erythrocyte dysmorphism.
Methods
Total of 128 spot urine specimens from 65 patients with glomerular diseases and 63 patients with nonglomerular diseases were included in this blind study. All specimens were analyzed by UriSed 3 Pro automated microscopy urine analyzer. The presence of erythrocytes was confirmed by using either an optical microscope or a phase-contrast microscopy.
Results
No acanthocyte flag message was found in samples with b5% of acanthocytes, samples without acanthocyte, and samples with doughnut cells and/or target cells. All of 7 urine samples from 4 patients with glomerular disease and 3 patients with nonglomerular diseases were demonstrated acanthocyte flag with the presence of N5% of acanthocytes. However, acanthocyte flag was not shown in 16 patients with glomerular diseases (5.7%-16.7% acanthocytes) and 7 patients with nonglomerular diseases (5.3% -33.3% acanthocytes).
Conclusions
Acanthocyturia were not specific for glomerular diseases. However, acanthocyturia was easy to detect from flag message of UriSed 3 Pro automated microscopy urine analyzer. 
Background-aim
Sepsis and septic shock represent a significant healthcare problem in intensive care units, strongly associated with morbidity and mortality. AKI is a frequent (20-50%) pathology sepsiscorrelated. Improvements in diagnostic procedures are required for effective management of infectious disease. Biomarkers as Presepsin (PRE) and Procalcitonin (PCT) contribute to monitoring sepsis and therapeutic interventions; creatinine is an indicator of renal function but serum concentration does not change until around 50% of kidney function is lost. NGAL, produced in kidney tubular cells after ischemic or nephrotoxic injury, can be detected in patient with AKI within 2-4 h. Moreover, NGAL exists as monomer specific to neutrophils and increases in inflammation state. In order to evaluate the role of NGAL in septic patients, eGFR, urinary NGAL, serum procalcitonin, and plasma presepsin were measured.
Methods 38 patients (14 with sepsis, 24 with septic shock) admitted to intensive care unit (24 M: median age 54y, 6 F: median age 59y), were recruited according to new criteria of severity and clinical diagnosis recommended by the 2016 Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Specimens were collected at baseline (T0), after 24 h (T1) and 48 h (T2). U-NGAL, S-PCT, P-PRE and S-Cre were measured using Architect i1000-Abbott, Liaison-Diasorin, PathFast-Mitsubishi and Vista-Siemens respectively. 
Results
Mean concentrations of biomarkers at
Conclusions
These preliminary data showed NGAL, PCT, and PRE values significantly higher in T2 compared to T0; no significantly difference was observed in eGFR. These data suggest the importance of sepsis multimarker approach to increase the antibiotic therapy success that could reduce the antibiotic resistance trouble. Further studies are needed to assess if NGAL increasing is due to leucocytic synthesis in response to sepsis or to reduced tubular reabsorption in response to AKI. 
Background-aim
Membranous nephropathy (MN) is an immune-mediated disease of the glomerular basement membrane. It occurs in primary form (PMN) or in association with other systemic diseases (secondary; SMN). The phospholipase A2 receptor (PLA2R1) has been shown as major podocyte antigen in PMN in the existing research. It is estimated that about 80% of PMN cases are positive for autoantibodies against PLA2R1. The aim of the present study was to compare serum levels of anti-phospholipase A2 receptor antibodies (anti-PLA2R1) in PMN patients with thouse of SMN patients and patients with other glomerulonephritis.
Methods
The study involved 113 participants, including 52 patients with PMN, 12 patients with SMN and 49 patients with others glomerulonephritis. Serum concentration of anti-PLA2R1 was determined using ELISA kit (Anti-PLA2R ELISA, IgG, EUROIMMUN, Lübeck, Germany) and MR-96A microplate reader (MINDRAY). Statistical comparisons were performed through the Kruskal-Wallis and MannWhitney U tests using SPSS software, version 24.0. The results were considered statistically significant at P b .05.
Results
The mean concentration of anti-PLA2R1 in patients with PMN was 213.97 ± 588.69 RU/ml, in patients with SMN 6.34 ± 11.68 RU/ ml, and in patients with others glomerulonephritis 3.52 ± 3.91 RU/ ml. The difference was statistically significant, P b .0001. Patients with PMN had a significantly higher concentration of anti-PLA2R1 compared to patients with SMN (P = 0,015) and those with other glomerulonephritis (P b .001). There was no statistically significant difference between patients with SMN and other glomerulonephritis (P = .191).
Conclusions
Our study suggests that anti-PLA2R is a specific biomarker of primary membranous nephropathy and might be used for diagnosis and disease activity monitoring. 
Background-aim
Urolithiasis is a common urologic condition with increasing incidence. The analytical study of kidney stones is important because it provides information about etiopathogenesis, therapeutic strategies and patient's prognosis.
Methods
This is an observational study stratified by sex and age. A total of 3679 stones were analyzed between 2015 and 2018 which came from different assistential levels.
The kidney stone analysis was carried out by combining two techniques: stereoscopic microscopy and infrared spectrometry (Spectrum Bx, PerkinElmer) for the identification and quantification of them, according to morpho-constitutional analysis. This allowed classifying the renal calculus in 6 main categories (defined by chemical composition and/or crystalline species) and 21 subcategories (defined by the morphological characteristics).
Statistical analysis was performed using the chi-square and Tstudent tests.
Results
Respect to sex, 2436 (66.2%) were from men and 1243 (33.8%) from women (ratio 1.96:1). The mean age was 52.4 years (IC95%:51.5-53.3) for women and 52.9 (IC95%:52.3-53.5) for men (p b .05). 50-59 year interval had the highest number of stones (24.7%), followed by 40-49 (20.6%) and 60-69 (20.5%).
2251 (61.2%) of the urolithiasis had a mixed composition and 1428 (38.8%) had a unique component. The combination of calcium oxalate monohydrate (COM) with calcium oxalate dihydrate (COD) was found in 644 (28.6%); COM with COD, apatite (APA) and struvite (ST) in 568 (25.3%) and COM with uric acid (UA) in 178 (7.9%). Those of a single component were COM 816 (57.1%), UA 414 (29%), phosphate (PHO) 70 (4.9%), proteins 67 (4.7%), COD 5 (0.4%) and cystine 9 (0.6%).
The most prevalent urolithiasis was COM (22.2%), followed by the mix of COM with COD (17.5%), COM + COD and PHO (15.4%) and UA (11.3%).
The prevalence of UA stones increases with age, being higher in men (16%) than in women (9%) (p b .05).
Infection stones appear as a mixed ST and APA and as "pure struvite" and are more prevalent in women (23%) than in men (8%) at all age ranges (p b .05).
PHO stones are more prevalent in the b29 year interval (32.3%) and decrease with age.
Conclusions
Combination of components in urinary stones reflects the multiple etiological mechanisms involved. It is important to highlight the great proportion of mixed stones. 
Background-aim
Chronic kidney disease (CKD) is a major public health issue worldwide because of its rising prevalence, poor outcomes and high cost of treatment. Proteinuria is associated with increased risk of CKD progression and death. Albuminuria and proteinuria are considered as first signs of kidney injury, significantly preceding other biochemical markers. There is no final conclusion whether urine albumin or urine protein excretion is the preferred measurement to assess glomerular function. KDIGO recommendations set the upper limit of "normal to mildly increased albuminuria/proteinuria" at 30/150 mg/24 h or 30/150 mg/g as a creatinine ratio (estimation of daily excretion). Although a value of albumin/creatinine ratio (ACR) of 30 mg/g is well documented, the question arises about contribution of other proteins to the amount of 150 mg/g creatinine. The main candidate fulfilling that gap is the Tamm-Horsfall glycoprotein (uromodulin) considered most abundant protein in urine of healthy human. We analyzed protein composition of 87 normal urine samples, evaluating total protein/creatinine ratio, albumin, uromodulin concentrations, and SDS electrophoresis protein pattern.
Methods
Albumin concentration was measured by latex immunoturbidimetric method (SIEMENS BN II), uromodulin by BioVendor ELISA Human Uromodulin kit, total protein by modified Bradford method. SDS electrophoresis was performed on commercial 4-20% gradient gels gradient gels (TruPAGE Precast Gels 4-20% Sigma Aldrich). Uromodulin was localized by immunoblotting using commercial Sigma Aldrich rabbit antibodies (1:250) and goat anti rabbit peroxidase conj. Antibodies (1:1000).
Results
All quantitative results were consistent with electrophoretic patterns where albumin was a major protein of normal human urine. The mean urine albumin concentration was 5.46 mg/L (ACR 7.55 mg/g). The mean total protein concentration was 14.87 mg/l (21.53 mg/g). Uromodulin concentrations did not exceed 25 mg/l in any sample. 
Conclusions
Background-aim
Proteinuria is often the first sign of kidney injury and is often discovered incidentally in a urinalysis.
Its presence, although it will not always indicate a pathological state, is usually related to an increased risk for the development of advanced kidney disease and cardiovascular diseases, so it is important to differentiate when it is a non-significant or transient proteinuria and when It is a manifestation of kidney diseases.
To differentiate the origin of proteinuria, different types of proteins with different clinical significance can be quantified, such as albumin, glomerular lesion marker; IgG, glomerular lesion marker with progression to nephropathy or alpha-1-microglobulin (A1MG), tubular lesion marker.
On the other hand, proteinuria may have a pre-renal origin due to overload, being the most frequent cause of this the monoclonal gammopathies, with high elimination of light chains. Its early detection is very important to diagnose lymphoproliferative diseases.
The objective of this work is to analyze the results obtained with the implementation of an algorithm for the differential diagnosis of proteinuria according to the origin of the proteins excreted in the urine.
Methods
A total of 4048 urine samples from patients who were requested for urinalysis with a protein-positive urine strip (N 25 mg/dL) and absence of leukocytes and/or nitrites were included.
The diagnostic algorithm used is to quantify albumin, total proteins and creatinine in urine as an indicator of the concentration and thus be able to use a spontaneous sample.
In the presence of protein/creatinine concentrations higher than 200 mg/g and a decrease in the albumin/total protein index lower than 0.6, the excretion of A1MG is measured as a tubular marker; In the presence of protein/creatinine concentrations between 200 mg/g and 3000 mg/g and albumin in urine N300 mg/dL, the excretion of IgG is also quantified to identify the selectivity and origin of the proteinuria.
If there is a decrease in the albumin/total protein ratio lower than 0.4, suggesting a pre-renal origin, quantification of kappa and lambda light chains was performed to ruled out a monoclonal gammopathy origin.
Results
The protein/creatinine concentration was lower than 200 mg/g in 2876 patients, between 200 and 3000 mg/g in 1077 and in 95 higher than 3000 mg/g.
A total of 560 patients were in the range of selective glomerular proteinuria.
A total of 369 patients had protein/creatinine ratio higher than 200 mg/g and albumin/protein ratio lower than 0.6, proceeding to the determination of A1MG, of which 58 were in the range of tubular proteinuria with probable tubulo-interstitial alteration.
A total of 330 patients with protein/creatinine ratio between 200 and 3000 mg/g had an albumin higher than 300 mg/L, proceeding to the determination of A1MG and IgG, of which 22 were in the range of selective proteinuria and absence of tubular proteinuria, 297 in the range of non-selective proteinuria and absence of tubular proteinuria, 11 in the range of mixed non-selective proteinuria with probable tubulo-insterticial alteration.
The determination of the K/L ratio was made in 93 patients, was altered in 13 of them and, after immunofixation, 8 patients were confirmed with monoclonal component.
Conclusions
This algorithm allows, from a spot sample of urine, to detect the presence of proteinuria and to guide the clinician about its origin, facilitating the choice of an adequate treatment to the existing nephropathy, which can avoid renal or cardiovascular complications. 
Background-aim
The study of urinary stone is fundamental since knowing its composition will allow to prevent recurrence, by introducing appropriate therapeutic and dietary measures that prevent or delay the appearance of associated complications. Know the chemical composition of urinary stones analyzed by evaluating the frequency in function of age and sex. As well as determine the percentage of recurrences in our population.
Methods
Retrospective observational study of the composition and distribution by age and sex of the urinary stones received in our section of renal function, in the period between 01/01/2010 to 01/01/2017. The samples were analyzed by stereoscopic optical microscopy and infrared spectrophotometry. The variables studied were: composition of the calculations, age, sex and origin of the samples.
The statistical analysis was carried out with the Microsoft Excel 2010 software.
Results 5244 episodes of urolithiasis were studied in 4037 patients. 67.7% of said samples they belonged to men and 32.3% to women, with an average age of 53.2 ± 15.3 years (range 0-100). By stripes of age we find: 0-20 years = 1%, 20-40 = 20%, 40-60 = 46%, 60-80 = 29% and N 80 = 3%. By provenance, the 52.4% of the requests are sent from urology followed by other laboratories (33.2%) and primary care (12.5%). 14.4% of the lithiases studied had a mixed composition. The qualitative distribution of calculations of pure composition was: calcium oxalate = 62.5%, uric acid = 13.6%, phosphates = 4.8%, struvite = 4.3% and cystine = 0.2%. Of the total number of patients, 12.7% (514) presented recurrences, being more frequent in patients with cystinuria (60%) followed by phosphatic lithiasis (20.8%).
Conclusions
The formation of urinary stones in our population is more frequent in men and in ages between 40 and 60 years. In terms of chemical composition, the most frequent is calcium oxalate followed by uric acid. It is crucial to insist on the importance of performing the study of the kidney calculi to make an approach to its etiopathology, prevention or treatment, especially in patients with recurrent lithiasis. 
Background-aim
Renal lithiasis is one of the most common conditions of modern society, constituting an important health problem that also has a great economic burden.. Despite the advances that have occurred in the management of this pathology, it continues to be a disease with high recurrence rate. It is estimated that after a first episode, between 30% and 50% will resort in the next 5-10 years. Improve the quality of care in patients who present a lithogenic risk (LR) to avoid a possible renal lithiasis and in those in which it has already occurred, prevent its recurrence.
Methods
Observational, retrospective study of urinary sediments performed by SEDIMAX (Menarini) of those urine in which crystalluria appears, taking into account the type of crystals, their combination, size and form, subsequently reporting the detection of lithogenic risk.
Results
During the period from July to December 2017, a total of 89,062 urine samples were routinely analyzed. The 45.9% of these presented a pathological strip, which is why their sediment is analyzed. In 881 (2.2%) the appearance of crystalluria associated with LR for different reasons; in 41.9% the combination of crystals of calcium oxalate monohydrate together with dihydrate, in 42.9%, oxalate crystals are observed calcium dihydrate with dodecahedral shape. Regarding the size, 73 sediments with calcium oxalate crystals dihydrate N35 μm and 61 with uric acid crystals N100 μm.
Conclusions
In view of these results, although given the large volume of samples that are analyzed the percentage of patients who present risk is not very high, it is decided during 2018 to improve the quality of care with the implantation in the urinary sediment report the LR result detected in the same, by the clinical assessment of various parameters of crystalluria from the study of nature crystal chemistry, crystal size, rate of aggregation and maclation, and the overall crystalline volume. In addition to informing the specialist, communication with the physician Primary Care is considered necessary and collaboration by nursing professionals for the implementation and follow-up of hygienic dietetic measures to improve the prevention of nephrolithiasis. 
Background-aim
Individual circadian rhythm of renal function through the estimation of glomerular filtration rate (GFR) has been described in scientific literature with higher values at the end of the resting phase. To continue with our research line, we aimed to describe if there is the same circadian pattern in the population values of glomerular filtration rate in two hospitals.
Methods
We studied 210,020 results of glomerular filtration values of samples collected over a period of 24 h. Data belong to two hospitals (A and B) whose patients were assisted at the emergency room from Jan 2013 to Dec 2017. Hospital A used dry chemistry technology (VITROS 5600 analyzer (Ortho Clinical Diagnostics®)) for creatinine determination and Hospital B used modified Jaffé method (AU-480 analyzer (Beckman®)). To avoid physiological differences patients were grouped by sex and those aged 15-85 years were selected (43.95% women, 56.5% men). GFR was calculated using the CKD-EPI formula and patients with GFR results between 90 and 120 ml/min/ 1.73 m 2 (stage G1) were selected. Statistical methods used were cosinor analysis and nonparametric index. We calculated TM5 (average of 5 consecutive hours with highest values) and TL10 (average of 10 consecutive hours with lowest values).
Results
Both population groups presented similar circadian patterns (p b .001). The highest values (TM5) were observed in the middle of the resting phase with a slight phase advance in the case of men (2:30 ± 0:07 vs 3:30 ± 0:11). In the case of women, lowest values (TL10) presented a phase advance (11:30 ± 0:09 vs 14:30 ± 0:09).
Conclusions
The circadian pattern observed in this population-based study is very similar to maximum and minimum values of GFR described in the literature for individual circadian rhythm. Results from this study suggest for very first time that our approach to look for circadian rhythms in population data is valid. Despite the large data used in this study, results should always be compared to individual patterns, as those already described in the literature. 
Background-aim
Urinaryalpha1-microglobulin (U-A1M) is a marker of proximal tubular damage. Its concentrations are elevated in urinary tract infection (UTI) and kidney diseases. Declared reference interval (RI) for alpha1-microglobulin in the second morning urine is b12 mg/L for nephelometric assay (Siemens, Germany). The aims of this study were to verify RI for U-A1Mi) in healthy asymptomatic females (group A) and ii) in asymptomatic females with laboratory findings indicative of UTI, albuminuria or proteinuria (group B).
Methods
Samples were obtained from asymptomatic volunteers who declared to be free from any acute disease, UTI and kidney disease. Second morning urine was collected from all study participants. Urinary dipstick and sediment analysis was done on automated urine analyzer Iris iQ200 (Beckman Coulter, USA). Protein-to-creatinine (PCR) and albumin-to-creatinine ratio (ACR) were determined on AU480chemistry analyzer (Beckman Coulter, USA). U-A1Mwas measured on BN Prospect (Siemens, Germany). U-A1M was reported as mg/L and as U-A1M/creatinine ratio (mg/mmol).Based on their test results, participants were divided into: group A (subjects with negative dipstick and sediment analysis whose ACR and PCR were normal), and group B (subjects who had positive either urinary dipstick, urinary sediment (bacteriaN5/μL, leukocytesN10/μL or erythrocytesN10/μL), ACR or PCR). Mann-Whitney test was used for statistical analysis, with P b .05 as a significance level.
Results
Median age did not differ between groups A (48 years, range 20-64) and B (53 years, range 21-63) (P = 0,262).In group A (N = 22) medianU-A1Mwas 5.78 mg/L (min-max were: 5.78-7.28). In group B (N = 29) median for U-A1Mwas 5.78 mg/L (interquartile range (IQR) 5.78-14.50). U-A1M did not differ between groups (P = .728). Median U-A1M/creatinine ratio in group Awas0.87 mg/mmol (IQR0.65-1.12). In group B median was 0.83 mg/mmol (IQR 0.63-1.15).U-A1M/creatinine did not differ between groups A and B (P = .834).
Conclusions
Manufacturer's reference interval can safely be adopted for female population in our laboratory.U-A1M and U-A1M/creatinine ratio cannot distinguish healthy females from asymptomatic females with laboratory findings indicative of UTI, albuminuria or proteinuria. 
Background-aim
Hypercholesterolemia may affect function of small arterioles and capillaries. In kidney, glomerular capillaries are part of glomerular filtration barrier (GFB). Its damage is an early first step in progression of chronic kidney disease. Structure and function of GFB may be affected oxidative stress. In this study we investigate impact of hypercholesterolemia under oxidative stress modification on GFB damage in vivo.
Methods
Male young rats (n = 12) were fed with 2% cholesterol diet for 18 days and then for next 10 days with 2 mM tempol (n = 4, superoxide dismutase mimetic), 20 mM buthionine sulfoximine (BSO, n = 4, ©-glutamylcysteine synthetase inhibitor) in drinking water (n = 4). 24-h urine collection was performed at 0, 18 and 28 day. Total protein excretion (TP) in urine was measured and glomerular damage was estimated based on nephrin excretion in urine. Oxidative stress was evaluated by excretion of 8-iso prostaglandin F2〈 (8-iso PGF2〈) and thiobarbituric acid reactive substances (TBARS).
Results
HCDH alone during 18 days led to increase TP (+19%, p b .01) and TBARS (+35%, p b .01) excretion and not significant changes of 8-iso PGF2〈 (+35%, p = .159) and nephrin (+51%, p = .397). Further 10 days of HCHD enriched of drinking BSO solution resulted in elevated excretion of nephrin (+280%, p = .013) and 8-iso PGF2〈 (+49%, p = .013) and not significant increase in TP (+6%, p = .50) and TBARS (+14%, p = .089). Tempol increased TBARS excretion (+15%, p b 0,01) but did not affect TP, 8-iso PGF2〈 and nephrin excretion (p N 0,14).
Conclusions
In conclusion, high cholesterol content diet may lead to disturbance in function of glomerular filtration barrier and this action is exaggerated by stimulation of oxidative stress. This may suggest an important role of oxidative balance during high cholesterol diet consumption in regulation of glomerular function. 
Background-aim
Atellica® UAS 800* system is an image based urine sediment analyzer that detects and reports 14 sediment analytes: RBC, WBC quantitatively, EPI, NEC, HYA, BAC, BACc, BACr, CRY semi-quantitatively and PAT, WBCc, YEA, MUC, SPRM qualitatively. In the Quality Control (QC) mode, Atellica UAS 800 system checks quantitative analytes RBC and WBC. In this poster, Atellica UAS 800 system's compatibility with four commercial QC materials (QCs) is reported. Urine specimens are often preserved to avoid sample deterioration. In this poster Atellica UAS 800 system's compatibility with two commercial preservative tubes is also reported.
Methods
Atellica UAS 800 system's QC-profile includes four QCs: DIP AND SPIN (Quantimetrix), QUANTSCOPICS (Quantimetrix), QUANTIFY Plus (Bio-Rad) and LIQUA-TROL (Kova). QC-ranges for RBC and WBC were estimated by measuring 20 replicates of two levels of each QC in sample-mode. Preliminary ranges were assigned by calculating the mean ± 3Xstandard deviation for each material. The QCs were subsequently measured in QC-mode for 5 times. The potential impact of preservative material on test specificity was estimated at the Limit of Detection (LoD) level for each analyte using sediment free blank urine with and without BD-VACUTAINER PLUS and BORITEX urine preservatives.
Results
The RBC and WBC concentrations of the QCs were within the assigned respective ranges. All replicates for each of the QCs recovered results within expected ranges. Preservative tube compatibility results indicated BAC and CRY LoD values were increased in the presence of BD preservative; PAT LoD value was increased to near negative-positive cutoff in the presence of Boritex preservative.
Conclusions
Atellica UAS 800 system is compatible with tested commercial QCs. In general Atellica UAS 800 system measurement is compatible with BD-VACUTAINER PLUS and BORITEX preservatives. The BAC LoD increase is below normal-abnormal cutoff. Increase in CRY and PAT LoDs were perhaps due to urine sample pH and composition preventing complete dissolution of the preservative materials and perhaps could be observed by any image based methodology.
*Not available for sale in USA. 
Background-aim
Background: Acute pancreatitis (AP) is a self-limiting disease in most patients, its severe form (SAP) develops in up to 20-30% of cases. In the case of acute kidney injury (AKI) complicating SAP, mortality can reach 50-80%. Early diagnosis of SAP is a key determinant of successful therapy and patients' survival.
The aim of the study was to determine the optimal formula for estimated glomerular filtration rates (eGFR) in patients with AP during the first 48 h, in the reversible phase of AKI development (KDIGO 2012).
Methods
Methods:
The study included 66 patients with AP (46 mild, 15 moderately severe and 5 with severe); 34 (51.5%) males and 32 (48.5%) females with mean age 61 ± 18.5 years admitted to the Surgical Department. Serum concentrations of creatinine was analyzed with Cobas 6000 Roche, and cystatin C with using Nephelometer BN II (Siemens). GFR was estimated with CKD-EPI equations and the kinetic equation (KeGFR) . In data analysis MannWhitney and Spearman tests were used as appropriate; p b .05 was considered statistically significant.
Results
Results: Mean values of eGFR calculated with using CKDEPIcreatinine, CKD-EPIcystatinC and CKD-EPIcreatinine+cystatinC formulas were significantly lower in patients with AKI than without AKI at the time of admission (46.5 ± 28.3 vs 85.6 ± 25; 53.7 ± 47.3 vs 92.8 ± 32.9; 49.7 ± 42.4 vs 90.6 ± 31.6 ml/min/1.73 m2; p b .0001) and the next 48 h (50.6 ± 32.6 vs 88.9 ± 26; 49.4 ± 35.5 vs 87.1 ± 34.5; 47.9 ± 33.7 vs 86.3 ± 31.7; p b .0001); respectively. In AKI patients, a statistically significant decrease in KeGFR was found comparing to patients without AKI (61.1 ± 37.1 vs 89.5 ± 33.7; p b .01). After 48 and 72 h of AP, KeGFR correlated negatively with serum cystatin C (R = -0,88; R = -0,88), urea (R = -0,79; R = -0,72) and creatinine (R = -0,78; R = -0,76) (p b 0,005). The KeGFR diagnostic sensitivity for AKI at 48 and 72 h of AP were 58% and 50%, and specificity 85% and 98% at the cut-off 56 and 44 ml/min/1.73 m2, respectively.
Conclusions
Conclusions: The monitoring of eGFR values with all CKD-EPI equations has similar diagnostic utility after 24 and 48 h of AP. The evaluation of KeGFR may be a predictive factor with potential diagnostic usefulness in AKI patients in the early phase of the AP and correlates with the severity of the disease. 
Background-aim
Acute kidney injury (AKI) is a serious clinical problem due to its high morbidity and mortality. The search for alternative markers for early diagnosis of AKI has been increasing due to the lack of early diagnostic of AKI. Myo-inositol oxygenase (MIOX) is the first ratelimiting enzyme of myo-inositol catabolism and is mostly observed in the kidney. In this study, the role of MIOX enzyme in the diagnosis of AKI induced by experimental ischemia-reperfusion injury in rats was investigated.
Methods
In total 40 rats were divided into 5 groups of 8 with simple randomization and left kidney ischemia reperfusion was applied to the experimental groups except the control group. Group 1 was evaluated as undamaged control group. Group 2 was exposed to 60 min ischemia and 2 h reperfusion. Group 3 was exposed to 60 min ischemia and 4 h reperfusion. Group 4 was exposed to ischemia for 2 h and reperfusion for 2 h. Group 5 was exposed to ischemia for 2 h and reperfusion for 4 h.
Results
Serum BUN and creatinine levels were higher in the experimental groups compared to the control group (p b .001). Serum MIOX levels were higher in groups 2, 3 and 4 than in the control group, but similar to the control group in group 5 (p = .002). Tissue MIOX levels were lower in groups 2, 4, and 5 than the control group (p = .039). Serum and tissue neutrophil gelatinase-related lipocalin (NGAL) levels were not significantly different when compared between the groups. Damage level in histopathologic examination; group 1 b group 3 b group 2 = group 4 b group 5 seems to be.
Conclusions
Serum MIOX levels are elevated in the early stages of AKI but are decreasing again in the following processes. Thus, serum MIOX level in the early diagnosis of AKI may be a potential promising marker. Serum BUN and creatinine levels are still the most important markers in the diagnosis of acute kidney injury. 
Background-aim
Urinary conductivity allows a coarse prediction of urinary osmolality in most cases, but is insensitive to the osmolal contribution of uncharged particles and presence of roentgen contrast media. Urinary osmolality can be estimated on the recently introduced Sysmex UF-5000 urine analyzer using conductivity. In this study, we evaluated the analytical performance of this research parameter. Secondary, we aimed to improve the manufacturer's algorithm for estimating urinary osmolality, based on standard urinalysis parameters (creatinine, glucose, relative density).
Methods
The analytical performance was determined and a prediction model to estimate urinary osmolality based on urinalysis parameters was developed. We further developed and validated a prediction model using another set of routine urine samples. In addition, the influence of roentgen contrast media on urinary osmolality was studied.
Results
The within-run and total imprecision for osmolality and conductivity measured on the Sysmex UF-5000 ranged from 1.1% to 4.9% and 0.7% to 4.8%, respectively. Multiple regression analysis revealed urinary creatinine, conductivity and relative density to be the strongest predictors to estimate urinary osmolality. A mean difference of 1.3 mOsm/kg between measured and predicted osmolality demonstrated that the predictive performance of our model was favorable. An excellent correlation between the relative density and % contrast media was demonstrated.
Conclusions
Urinary osmolality is an important parameter for assessing specimen dilution in urinalysis. Urinary conductivity, along with relative density and urinary creatinine allows a coarse prediction of urinary osmolality, and is insensitive to the osmolal contribution of uncharged particles and the presence of roentgen contrast media. 
Background-aim
Lupus nephritis (LN) is a common cause of chronic kidney disease and end-stage renal disease requiring dialysis in South Africa. A noninvasive, easy to obtain and accurate biomarker that is able to discriminate disease activity and severity, predict flares, and monitor treatment response and disease progression would be very useful in guiding patient management. Within the kidney, locally secreted chemokines and cytokines such as monocyte chemoattractant protein-1 (MCP-1) and Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK), respectively, are instrumental in the pathogenesis of LN and may therefore have the potential to accurately reflect renal inflammatory disease activity in LN. This study aimed to assess the correlation between urinary MCP-1 and TWEAK concentrations, and disease activity in patients with lupus nephritis in Cape Town.
Methods
A cohort of fifty patients was recruited from the Nephrology Clinic at Groote Schuur Hospital. This consisted of (i) a clinically stable group with quiescent LN (n = 30) and (ii) an active disease group (n = 20) made up of newly biopsied LN. Relevant demographic and standard biochemical data were collected from each group. Urinary MCP-1 and TWEAK were measured by Enzyme-linked Immunosorbent Assay (Quantikine ELISA, R&D Systems and eBioscience, Thermo Fisher, respectively). Absolute analyte values in pg/mL, as well as values standardized to urine creatinine as pg/mgCr were assessed. Statistical analysis was performed for non-parametric data using Stata14 (StataCorp LLC). A p value b.05 was deemed statistically significant.
Results
Demographic features (age, gender and race) were similar in both groups. At visit 1, serum creatinine was not significantly different between the groups (p = .109), however, disease activity index (SLEDAI score) was significantly higher in the active group (p b .001). Patients with active LN demonstrated significantly higher urinary MCP-1 and TWEAK concentrations than patients in the quiescent group [data described as median (P25; P75): 1440 (683; 2729) vs 256 (175; 477) pg/mL; p b .001 and 209 (117; 312) vs 74 (11; 173) pg/mL; p 〈001]. When the patients' MCP-1 and TWEAK results were corrected for their urinary creatinine concentrations, the active group demonstrated values that were again significantly higher than the quiescent group: cMCP-1 [1093 (577; 2014) vs 286 (138; 774) pg/mgCr; p b .001] and cTWEAK [159 (89; 296) vs 63 (26; 160) pg/mg Cr; p = .02]. Furthermore, the results for MCP-1 and TWEAK, and cMCP-1 and cTWEAK were correlated in the active group (R-squared = 0.8, p b .001 and 0.9, p b .001, respectively).
Conclusions
As per previous studies in other countries, our data suggests that the urinary biomarkers MCP-1 and TWEAK reflect renal disease activity in our South African cohort of LN patients and could be useful for screening, diagnosis and disease activity monitoring. 
Background-aim
To investigate the association of lipid profile parameters and etiology of chronic kidney disease (CKD).
Methods
The study enrolled patients (n = 73) recruited from the Nephrological Counselling Centre of the University Clinical Centre, Sarajevo whose estimated glomerular filtration rate (eGFR) was b60 ml/min/1.73 m 
Background-aim
Nocturnal enuresis is defined as bed wetting in children older than 5 years of age that occurs during sleep. Nocturnal enuresis is a complicated disease that includes multiple pathogenetic factors. Nocturnal enuresis is divided into two subgroups: monosymptomatic and non-monosymptomatic. The aim of this research was to evaluate the possible role of copeptin and corticotropin-releasing factor (CRF) levels in monosymptomatic and non-monosymptomatic nocturnal enuresis cases.
Methods
One hundred nineteen children with nocturnal enuresis and forty healthy children have enrolled in the study. Of the nocturnal enuresis group, forty-nine were monosymptomatic and 70 were non-monosymptomatic. Copeptin and CRF were measured via a competitive inhibition method with ELISA.
Results
The study group was composed of 119 children with nocturnal enuresis; forty-nine were monosymptomatic and 70 were nonmonosymptomatic. Only nine patients had received desmopressin in the past, and all of them were nonresponders. The mean copeptin and CRF levels were significantly lower in children with both monosymptomatic and non-monosymptomatic nocturnal enuresis. The mean CRF level was significantly higher in nine patients who had received desmopressin and had not responded in comparison with the other nocturnal enuresis patients.
Conclusions
We demonstrated that the central nervous system and neurotransmitters such as copeptin and CRF play a role in children with both monosymptomatic and non-monosymptomatic nocturnal enuresis. We also found increased CRF levels in children who were nonresponsive to desmopressin acetate. Our study suggested that high plasma CRF levels before treatment may be a predictive marker for resistance to desmopressin acetate. 
Background-aim
Chronic kidney disease (CKD) is a general term for heterogeneous disorders affecting kidney structure and function. In the end stage of the disease, patients are treated with renal replacement therapy: hemodialysis or peritoneal dialysis. CKD also results in abnormal lipid metabolism. Lipid disorders start early in the course of CKD and worsen with the progress of the disease. The most typical alterations are changes in triacylglycerols (TAG) and high-density lipoprotein (HDL) cholesterol level. However, still little is known about changes in the composition of serum fatty acids (FA) in patients with endstage renal disease and consequences of these alterations on lipid metabolism. The aim of this study is to investigate the lipid profile of patients during hemodialysis and peritoneal dialysis and the effect of observed changes in FA profiles on the expression of genes involved in lipid metabolism.
Methods
In the serum of patients treated by renal replacement therapy, the FA profile was determined using the GC-MS method. The results were compared with the control group in which no abnormalities in the functioning of the kidneys were found. The selected FA, which content changes in patients treated with renal replacement therapy, were used for treatment of in vitro hepatocytes culture for a period of 48 h. RNA was then isolated from cells and the level of gene expression associated with lipid metabolism was determined using real-time PCR.
Results
In patients treated with renal replacement therapy, the content of n-6 polyunsaturated fatty acids (n-6 PUFA) in serum were reduced and the content of monounsaturated fatty acids (MUFA) were elevated. Results in both investigated groups (hemodialysis and peritoneal dialysis) were similar. Supplementation of hepatocytes with MUFA increased the expression of genes responsible for the synthesis of fatty acids and triacylglycerols. N-6 PUFA fatty acids have the opposite effect.
Conclusions
Patients during hemodialysis and peritoneal dialysis present similar lipid profile in the serum. Observed changes in FA profile can increase lipid synthesis in liver and may contribute to hypertriglyceridemia in CKD patients. 
Background-aim
Atellica® UAS 800* system can report 14 urine sediment analytes: RBC, WBC, WBCc, EPI, NEC, HYA, PAT, BAC, BACc, BACr, CRY, YEA, MUC and SPRM. The result outputs include microscopic images that allow users to review the result. In this poster, Atellica UAS 800 system's normal-abnormal thresholds, linearity ranges of quantitative parameters, and the effects of the sampling process on carry over and sediment particle integrity are reported.
Methods
Deidentified specimens were used in the studies. To estimate the normal-abnormal threshold 245 randomly collected urine samples (153 male and 92 female self-identified healthy donors) were analyzed on Atellica UAS 800. The upper limits of normal ranges were defined as the 95th-percentile of reported results for each analyte. Analytical linearity ranges for quantitative analytes, RBC and WBC were determined by using serially diluted specimen of high RBC or WBC concentration. Each diluted sample was analyzed in 4 runs in a random order. Deviations from linearity were estimated by fitting 1st, 2nd and 3rd order polynomials to the results. Carryover was determined for clinically prevalent analytes RBC, WBC and BAC. Carryover studies were performed by repeating 10 sequences of 3 runs of high concentrated samples (a1, a2, a3) followed by 3 runs of negative samples (b1, b2, b3). Carryover was calculated as (b1-b3) X100/(a3-b3). Effect of sample mixing on cellular integrity was measured for RBC, one of the unstable analytes. The effect was determined by measuring the RBC concentration changes in successive 7 replicates.
Results
Normal-abnormal thresholds were 7/μL RBC, 15/μL WBC, 336/μL BAC, 0/μL CRY and 3.5/μL YEA. The linearity ranges for RBC was 4-1600/μL and WBC was 3-900/μL. Carryover values for RBC, WBC and BAC were 0% (less than respective limits of quantitation). Sample mixing impact study showed less than ±3% change in RBC concentration in successive 7 measurements.
Conclusions
Atellica UAS 800 system's normal-abnormal thresholds are similar to literature reported ranges. The analytical ranges for RBC and WBC span from respective negative levels to pathologically high concentrations. The sampling process does not cause carryover or cell lysis.
Background-aim
Several equations using serum creatinine are used in clinical practice to estimate glomerular filtration rate (GFR). The Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend to use the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation. Recently, a new equation has been proposed by a European group which could better fit thorough the whole age range: the Full age spectrum equation (FAS). In the current analysis, we studied concordance and discrepancies between CKD-EPI and FAS equations in a large laboratory database.
Methods
We conducted a monocentric retrospective study on all ambulatory adult patients (N 18 years) who benefited of serum creatinine measurements at our university hospital, from January 2018 to November 2018. GFR was estimated by CKD-EPI and FAS equations. Serum creatinine was measured with the IDSM standardized enzymatic method from Roche on Cobas. The CKD classification proposed by the KDIGO was used with eGFR (in mL/ min/1. 
Results
A total of 58,366 subjects was considered (56.9% of women) with a mean age of 53 ± 18 years old. Stage 1 represents 50 and 42% of the whole population according to CKD-EPI or FAS equations, respectively. Stage 2 represents 37 and 40%, stage 3a represents 8 and 11%, stage 3b represents 4 and 5%, stage 4 represents 1.4 and 1.6% and stage 5 represents 0.7 and 0.5%. Concordant classification was observed between CKD-EPI and FAS in 84% of the whole population. According to the different stages, concordance was 84, 85, 76, 91, 91 and 79% in stage 1, 2, 3a, 3b, 4 and 5, respectively. Concordance was not influenced by gender but well by age as we observed a concordance of 93, 95%, 80%, 71, and 52% in subjects aged between 18 and 30, 30 and 50, 50 and 70, 70 and 90 , and over 90 years, respectively.
Conclusions
In this large laboratory database, the global concordance of FAS and CKD-EPI equation to classify patients in the CKD staging is 84%. Higher discrepancies are observed with aging and in stage 3a and 5. 
Background-aim
Kidney Disease Improving Global Outcomes (KDIGO) has proposed a consensus definition for acute kidney injury (AKI) based on serum creatinine (SCr) changes. AKI is defined as increase in SCr N0.3 mg/dl OR increase in SCr to N1.5 times baseline. We aimed to investigate if these two criteria have the same impact on the prevalence of AKI in hospitalized patients.
Methods
Between September and November 2018, we extracted data on all SCr results from all hospitalized patients that had at least five SCr measurements. Only first hospitalization was considered and all available SCr results were used in our analysis. Dialysis patients at admission were excluded. SCr was measured with an enzymatic method on Cobas, Roche.
Results
Results from 947 patients were analyzed. A mean of 14 ± 9 results per patient were available. AKI, with the ε0.3 criterion, was diagnosed in 32.10% of patients vs only 18.3% when the N1.5 times baseline criterion was applied. Diagnosis was concordant only in 17.8% of the patients. Only 4 patients with low baseline SCr (mean at 0.42 mg/dL) had AKI with ε1.5 criterion, and not with ε0.3 criterion. On the other hand, 135 patients were AKI with the ε0.3 criterion only. Among these 135 patients, 75 (55%) had only one SCr result 0.3 mg/dL higher than the baseline SCr (all other SCr results changes being lower than 0.3 mg/dL). Further analysis dividing patients in 3 subgroups according to baseline SCr (subgroup-1 = SCr b 0.7 mg/dL, subgroup-2 = SCr between 0.7 and 1.3 mg/dL and subgroup-3 = SCr N1.3 mg/dL) showed that: In subgroup-1(n = 203), the prevalence of AKI was 18.5% and 19.5% with the ε0.3 and ε1.5 criteria respectively, in subgroup-2 (n = 453), it was 29.4% and 19.0% and finally in subgroup-3 (n = 289), the prevalence was 46.0% and 16.3%.
Conclusions
The ε0.3 criterion is associated with a much higher prevalence of AKI, compared to the ε1.5 criterion. This is more obvious in patients with higher baseline SCr. Higher increases might be needed in order to be considered significant for AKI diagnosis. N55% of AKI patients with ε0.3 criterion and not the ε1.5 criterion had only one isolated abnormal change in SCr value, suggesting few clinical consequences. Further studies are required to study the impact of these two criteria on clinical outcomes. 
Background-aim
Total calcium is routinely used in diagnosis and monitoring; numerous laboratory adjusts total calcium by albumin using Payne's formula (or other local formulas adapted from Payne). Literature suggests some limits to calcium adjustment formula. We reported a large retrospectively study on agreement rate to compare calcium status by ionized calcium measurement to total calcium and albumin-adjusted calcium.
Methods
All samples were analyzed on Roche Cobas 8000® analyzer module c701/702 (Bâle, Suisse) to measure total calcium, albumin levels, creatinine. Ionized calcium and pH are measure on ABL 800 flex (Radiometer, Brønshøj, Danemark). We subgrouped our patients according to their eGFR (estimated Glomerular Filtration Rate), albumin levels and pH. We characterized each patient calcium state with ionized calcium (used as reference) to determine agreement rate with total calcium and albumin-adjusted calcium by Payne formula.
Results
We retrospectively selected 5055 samples with simultaneous measurement of ionized calcium, total calcium, albumin and pH. For patients with normal albumin levels, globally patients with eGFR N90 mL/min in acidosis leads to an underestimation of calcium state with total calcium and adjusted calcium. Patients with eGFR b30 mL/ min in alkalosis leads to an overestimation of calcium state. For patients with low albumin levels, total calcium and corrected calcium misclassify calcium state. Patients with eGFR N90 mL/min, agreement rate between total calcium and ionized calcium is around 65% for the calcium state. Globally agreement rate between ionized calcium and corrected calcium, with albumin levels under 35 g/L are low, especially in alkalosis where adjusted calcium overestimate calcium state for 60%.
Conclusions
Total calcium measurement and albumin-adjusted leads to a misclassification of patient calcium state. Calcium state determination depends on pH blood levels which measurement requires the same pre-analytical restrictions than ionized calcium measurement. So, if pH measurement is necessary to predict misclassification of calcium state for total calcium adjustment, ionized calcium measurement could be performed to determine the real calcium state without possible error. 
Background-aim
Serum retinol levels are significantly increased in hemodialysis (HD) patients compared to healthy subjects and lower retinol represents an independent mortality predictor. There are no data concerning retinoic acid (ATRA -all-trans retinoic acid) the main derivative of retinol in hemodialysis patients so far and there is even no commercially available method for its determination. The aim was to establish a method for determination of ATRA in human serum and to find out the significance of ATRA in long-term HD patients.
Methods
ATRA was measured with by high-performance liquid chromatography (HPLC). Serum levels of ATRA and their significance were evaluated in 247 long-term HD patients followed up for five years and 54 controls.
Results
We have introduced a fast, simple and reliable HPLC method for determination of ATRA in human serum (LOD 0.21 ng/ml, LOQ 0.70 ng/ ml) giving the same results in serum as in plasma. Variability within run and between runs was 4.31% and 9.55%, respectively. This method enables simultaneous measurement of retinol. Despite higher serum concentrations of retinol in HD patients, ATRA is decreased (median (interquartile range) 1.13 (0.90-1.60) ng/ml in HD patients vs. 1.42 (1.08-1.63) ng/ml in controls, p = .02) and is also a significant mortality predictor (HR (95%CI) 0.804 (0.694-0.931), p = .004).
Conclusions
Retinoic acid is decreased in HD patients compared to healthy subjects and lower ATRA is a significant mortality predictor.
Acknowledgements: Supported by research projects MH CZ DRO VFN64165 and Progres Q25. 
Background-aim
All physiological processes are subjected to a circadian variation. In clinical laboratory, the study of circadian rythm is limited to some hormone concentrations. The main challenge in these studies is data collection from the same patient during 24 h. The study of population values instead of one subject data could be a solution for this problem, and there are some preliminary studies in this line. The purpose of this work is to study the circadian variation of the glomerular filtrate and the hematocrit using paired population data.
Methods
We analyzed 219,774 blood samples (49.22% women) from patients aged from 15 to 85 years, who went to our hospital emergency room from January 2013 to December 2017. All samples had available analysis of creatinine (AU480, Beckman®) and hematocrit (DxH800, Coulter®) and the estimation of glomerular filtration (GF) rate (CKD-EPI) was calculated. Only those patients with GF rates higher than 90 mL/min/1.73 m 2 (144,932, 53.19% women) were selected. A subgroup of women aged from 45 to 85 years was made to avoid possible interferences of hematocrit due to the ovarian cycle. All data was grouped by sex and hour. We calculated the waveform of all data by 30-min intervals and performed a regression analysis between both parameters only during the daily activity phase (8: 00-23: 00 h).
Results
We found a clear inverse correlation (r = 0.8506, p b .001) between the GF and hematocrit values in men during the activity phase. We didn't observe any correlation between both variables in women, except in the older age subgroup, which showed similar behaviour to men (r = 0.7426, p b .001).
Conclusions
Results of this work are very promising. The big sample size is a differentiating factor in this study. To our knowledge, this is the first study of correlation performed in such a big simple. In addition, the inverse correlation found in daily patterns between both variables can be physiologically justified, as hematocrit value is a good indicator of hemodilution. This work suggests that the study of population data circadian rhythms may constitute a new research field in clinical diagnostic laboratory. 
Background-aim
Chronic kidney disease (CKD) is a major medical problem. The absence of adequate pre-dialysis treatment results in high morbidity and mortality of patients. All chronic kidney diseases have similar clinical symptoms of advanced stages, e.g. a decrease in glomerular filtration and the development of non-selective proteinuria. Non-coding micro RNAs (miRNAs) can be used as marker for CKD. miRNAs are involved in posttranscriptional regulation of gene expression. The effect of miR-376a is in the repression of cyclin dependent kinase 2 and Ago2 activity, cell cycle deregulation and the inhibition of cell proliferation.
Methods
In the study, biological material of the experimental group consist of plasma of patients with chronical kidney diseases, from the Fresenius Medical Care -dialysis centre in Košice. Patients in the first experimental group (n = 10) had a confirmed diagnosis of chronical kidney diseases. The second group was patients with cardiac comorbidity (n = 10) diagnosed with CKD. After isolation and specific purification of miRNA-376a, reverse transcription into cDNA was used.
Results
Analysis of expression levels was performed by qReal-Time PCR. In the quantification of miRNA, a comparative CT method was used. In the dialyzed patient group, 2-⊗ ⊗CT values for miR-376a were detected. In the cardiologic comorbidity group, the 2-⊗ CTT values upregulation of miR-376a were confirmed. Similarly, high levels of miR376a were detected in patients with urothelial bladder carcinoma.
Conclusions
The obtained results confirmed that the miR-376a analysis could be used in the future to diagnose kidney disease and monitor the dialyzation effect of chronically dialyzed patients. This work was supported by project VEGA 1/0372/17. 
Methods
This was a cross sectional study involving total 207 participants, and grouped as patients group, having 138 end stage renal disease (ESRD) patients maintenance haemodialysis (more than one year) with mean age 53.30 ± 13.3, and 69 healthy participant (age and sex-matched) with mean age 54.23 ± 10.7, were selected as controls group. 138 ESRD Patients were enrolled from National kidney centre, Sumeru Hospital and Golden Hospital Nepal from July 2016 to September 2018. For molecular study, DNA was extracted form whole blood by using Thermo Scientific gene JET Genomic DNA purification kit (lot no: 00653998) and for amplification of DNA, we were used conventional PCR with primers as BsmI (forward primer 5'CAACCAAGACTACAAGTACCGCGTCAGTGA3' and reverse 5' AACCAGCGGGAAGAGGTCAAGGG 3′) and FokI (forward 5' AGCTGGCCCTGGCACTGACTCTTGCTCT 3′ and reverse 5' ATGGAAACACCTTGCTTCTTCTCCCTC 3′). The two major Vitamin D receptor Gene polymorphism (BsmI and FokI) were genotyped by adopting Polymerase chain reaction -Restriction fragment length polymorphism (PCR-RFLP) techniques at Annapurna research centre Nepal. Serum levels of total Vitamin D were measured by electrochemiluminescence assay (ECLIA) method, and other Calcium, Phosphorus, Urea and Creatinine were investigated by auto-analyzer to determine the association between healthy control and ESRD patients. Statistical analysis was done using SPSS program, chisquare test, Hardy-Weinberg equilibrium using Pearson's Chisquared goodness of fit test were used.
Results
Enrolled 138 ESRD patients were significantly (P b .05) low serum vitamin D level (13.76 ± 6.59) as compared to 69 healthy control having serum vitamin D level (32 ± 10.27). BsmI genotyped frequencies were BB (n = 67), Bb (n = 57) and bb (n = 14) in ESRD patients group whereas BB (n = 36), Bb (n = 25) and bb (n = 8) in healthy control group (χ 2 = 0.51 P = .775). FokI genotyped frequencies were FF (n = 74), Ff (n = 56) and ff (n = 8) in ESRD patients group and FF (n = 34), Ff (n = 32) and ff (n = 3) in healthy controls group (χ 2 = 0.71, P = .700). While B and b alleles frequencies were 69.2% and 30.8% respectively in the patient group and 70.3% and 29.7% respectively in the control group (χ 2 = 0.51, P = .821).
Frequencies of F and f alleles were 73.9% and 26.1% respectively in patient group and 72.6% and 2.5% respectively in control group (χ 2 = 0.09, P = .753). No statistically significant deference in Vitamin D polymorphism (BsmI and FokI) genotypes frequency, were observed between haemodialysis ESRD patients and healthy controls, which suggesting that pathogenesis of ESRD had no association with Vitamin D receptor BsmI and FokI gene polymorphism.
Conclusions
This results suggested that high prevalence of hypovitaminosis D in ESRD patient as compared to healthy control and Vitamin D polymorphism (BsmI and FokI) are not associated with ESRD among Nepalese Population. 
Background-aim
The normal circadian pattern alteration of any physiological process is called chronodisruption. This alteration is known to be related to age and to numerous pathologies development. Our group has analyzed population data of various analytes ordered by the extraction time. The objective of this study is to see how glomerular filtration values change according to chronic kidney disease staging.
Methods
We collected creatinine values from patients assisted at the hospital emergency room between Jan 2013 and Dec 2017, and only patients aged 15 to 85 years were selected. (171,392 women's samples and 230,798 men's samples) Glomerular filtration (GF) was calculated using the CKD-EPI formula and results were grouped into 6 sets: G1, with GF between 90 and 120 mL/min/ (14,479, 39.49%) . The average age of women was: 54.8 ± 15.4 (G1); 71.4 ± 12.7 (G2); 74.6 ± 10.3 (G3a); 75.1 ± 10.7 (G3b); 73.3 ± 12.4 (G4) and 67.9 ± 14.4 (G5). In the case of men: 56.9 ± 14.5 (G1); 69.6 ± 12.7 (G2); 72.2 ± 10.9 (G3a); 72.8 ± 10.7 (G3b); 71.4 ± 11.7 (G4) and 66.3 ± 13 (G5). In all sets, we calculated waveform with data grouped by 30 min intervals and we used Cosinor method adjusting to cosine function.
Results
Only G1 group, in both men and women, showed a circadian pattern with higher values at the beginning of the activity phase (p b .001). For the rest of the groups, the adjustment to the cosine function was not significant.
Conclusions
In the case of glomerular filtration, an analysis of the population data is similar to the individual circadian rhythm. This work shows that age and the progression of chronic kidney disease carry a loss of circadian rhythmicity. It is described, that the innate immune system can alter tumor growth and that overexpression of NOD1 can promote apoptosis.
Aim of the study was to characterize NOD1 and NOD2 expression in human clear cell renal cell carcinoma (ccRCC) and healthy renal tissue.
Methods
Tumor tissues and corresponding healthy tissues from 33 patients with histopathological diagnosis of ccRCC and tumor tissue from a murine xenograft model using CAKI-1 ccRCC cells were analyzed. Paraffin embedded biopsies as well as primary isolated renal tubular and tumor cells grown in chamber slides were used for immunohistochemistry and immunofluorescence staining. Furthermore, mRNA was isolated and analyzed with qPCR.
Results
NOD1 and NOD2 expression were found in ccRCC as well as in healthy renal tissue from the same donor. In tumor tissue NOD1 mRNA levels were significantly lower and NOD2 significantly higher compared to the corresponding healthy tissue.
NOD1 showed cytoplasmic as well as nuclear localization, whereas NOD2 was exclusively located in the cytoplasm of ccRCC and healthy tissues.
In blood vessels NOD2 showed broader expression than NOD1. In the murine xenograft model human NOD1 mRNA was significantly higher expressed compared to NOD2. In contrast, mouse NOD1 showed lower mRNA expression compared to NOD2.
Conclusions
In summary, it can be stated that NOD receptors seem to be modulated in tumorigenesis of ccRCC plus its vasculature, which can offer new therapeutic strategies in ccRCC treatment. 
Background-aim
The aim of this study was to compare the efficacy of glomerular filtration rate (GFR) estimations derived from various estimated creatinine clearance methods such as Jelliffe, Cockcroft and Gault, and 4MDRD equations as compared to measured glomerular filtration rate (GFR) in a population of Indians.
Methods
We enrolled 80 patients in the study. GFR was determined by measuring technetium-99 m diethyl triamine penta-acetic acid (Tc99mDTPA) clearance. Height, body weight, and serum creatinine were measured, and GFR and creatinine clearance (CrCl) estimates were calculated by various equations. Spearman's correlation was used to assess relationships between measured GFR (Tc99mDTPA clearance) and estimated clearances using the three formulae. Differences between the measured GFR and estimated clearances were examined to determine whether prediction error was independent of measurement magnitude. Analyses of differences were used to determine bias and precision. Bias was assessed by mean percentage error (MPE), calculated as the percentage difference between the estimated clearances for each formula and measured GFR. A positive bias indicates overestimation of GFR, and a negative bias indicates underestimation. Relationships were also assessed by gender and varying levels of renal function: GFR b 60 ml/min, and GFR N 60 ml/min.
Results
The mean measured GFR was 77.2 ml/min (range 17−152 ml/ min). The mean bias (mean percentage error) was −4.9, −10.3, and − 1.57% for the Jelliffe, Cockcroft and Gault, and 4MDRD formulas, respectively. The 4 MDRD formula slightly overestimated the GFR in patients having a GFR b60 ml/min, whereas it underestimated for GFR values N60 ml/min.
Conclusions
In Indians, the 4 MDRD equation of estimated creatinine clearance seems to be most efficient for estimating GFR. 
Background-aim
With a rising incidence in renal failure, chronic kidney disease (CKD) has become one of the leading health conditions in the U.S. The earlier stages of CKD generate few symptoms and only until the kidney is significantly impaired do patients begin experiencing signs of renal failure. Parathyroid hormone (PTH) is a key biomarker in patient diagnosis and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), as well as hypo/hyperparathyrioidism. Elevated levels of intact PTH (iPTH) have been associated with CKD Stages 3-5. The most recent update of the Kidney Disease Improving Global Outcomes (KDIGO) guideline for CKD-MBD management emphasized the role of PTH as one of the key biomarkers of this disorder. Intact PTH, secreted normally into the blood at 10-65 pg/mL concentration levels, can undergo oxidative or enzymatic metabolic cleavages within parathyroid glands or peripheral tissues to produce N-terminal, C-terminal, and mid-range fragments. The ratio of these PTH fragments to iPTH has been diagnostic for severe or end-stage renal disease, non-dynamic bone disease, and hyperparathyroid-associated bone loss. Current PTH immunoassays demonstrate significant variability with up to a 4.2 fold difference in measurements depending on the method used. This variability can lead to misclassification of patients. Such significant variability has been attributed to differences in antibody specificity, lack of accurate calibration, matrix effects, or interferences. This creates the need for a new accurate and specific method to measure PTH and its fragments. In addition, the low endogenous concentration of PTH in biological matrices requires both, a highly sensitive and specific methodology. The CDC Clinical Standardization Programs in collaboration with the Partnership for the Accurate Testing of Hormones is addressing this need. This work highlights a novel high resolution mass spectrometry-based reference measurement procedure for intact PTH (1-84) and its fragments.
Methods
A reference measurement procedure was developed for the quantitation of intact PTH (1-84) and select PTH fragments in serum. Stable isotope labeled internal standards were spiked prior to sample preparation. PTH isolation was optimized using immunocapture methodologies. Briefly, mass spectrometric immunoassay (MSIA) pipette tips were embedded with various monoclonal and polyclonal antibodies. Analytes were eluted from the MSIA tips into 96-well plates for analysis. A Thermo Scientific Q Exactive Plus mass spectrometer operating at 70,000 resolution was coupled to a Dionex Ultimate 3000 XRS UHPLC system for data acquisition. Separation was achieved using a Proswift RP-4H (1 × 250 mm) monolith column under reversed phase gradient conditions at 50°C.
Results
Initial results demonstrate the ability to quantify intact PTH and PTH fragments with high specificity. Calibration curves using stable isotope labeled internal standards were generated for iPTH, Nterminal PTH fragments, C-terminal PTH fragments, and mid-region PTH fragments. Initial assessments demonstrate excellent linearity (R 2 = 0.991-0.997), reproducibility, and sufficient sensitivity of the UHPLC-HRMS system with a linear range of 15-3000 pg/mL PTH. The within-run imprecision (%CV) between 3 technical replicates over this concentration range was 0.1-6.4%. The chromatographic drift (% CV) between instrument technical replicates over this concentration range was b1% over the course of 17 h. This method was applied to samples from healthy patients and patients with different CKD stages. PTH and its fragments were detectable in these samples.
Conclusions
Reliable PTH measurement methods are essential for correct disease detection, prevention and patient care. This work demonstrates the first UHPLC-HRMS reference procedure to provide topdown quantitative measurements for intact PTH and related fragments without enzymatic digestion. Future work includes the assessment of alternative sample preparation and mass spectrometric approaches to improve the PTH sensitivity of the reference measurement procedures. In addition, work is underway to include additional PTH related fragments. doi:10.1016/j.cca.2019.03.1037
